CINXE.COM

Baricitinib - Wikipedia

<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>Baricitinib - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy", "wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"02302374-e3e9-4b7b-a782-f1609a875b36","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Baricitinib","wgTitle":"Baricitinib","wgCurRevisionId":1258014091,"wgRevisionId":1258014091,"wgArticleId":36106433,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Source attribution","Articles with short description","Short description matches Wikidata","Use dmy dates from February 2023","Drugs with non-standard legal status","ECHA InfoCard ID from Wikidata","Articles containing unverified chemical infoboxes","Articles containing potentially dated statements from August 2016","All articles containing potentially dated statements","Wikipedia articles in need of updating from April 2020","All Wikipedia articles in need of updating", "Articles containing potentially dated statements from March 2022","All articles with unsourced statements","Articles with unsourced statements from October 2022","Articles containing potentially dated statements from April 2021","Anti-inflammatory agents","Azetidines","COVID-19 drug development","Janus kinase inhibitors","Pyrazoles","Pyrrolopyrimidines","Sulfonamides","Disease-modifying antirheumatic drugs","Nitriles"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Baricitinib","wgRelevantArticleId":36106433,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"}, "wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":40000,"wgRelatedArticlesCompat":[],"wgCentralAuthMobileDomain":false,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q4860707","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready", "skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession", "wikibase.sidebar.tracking"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022"> <script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.4"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/1200px-Baricitinib_structure.svg.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="1896"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/800px-Baricitinib_structure.svg.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="1264"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/640px-Baricitinib_structure.svg.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="1011"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="Baricitinib - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Baricitinib"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Baricitinib&amp;action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/Baricitinib"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom"> <link rel="dns-prefetch" href="//meta.wikimedia.org" /> <link rel="dns-prefetch" href="//login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Baricitinib rootpage-Baricitinib skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span> <span class="vector-dropdown-label-text">Main menu</span> </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <span class="mw-logo-container skin-invert"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </span> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page&#039;s font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span> <span class="vector-dropdown-label-text">Appearance</span> </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" class=""><span>Donate</span></a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&amp;returnto=Baricitinib" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&amp;returnto=Baricitinib" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span> <span class="vector-dropdown-label-text">Personal tools</span> </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Baricitinib" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Baricitinib" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"><!-- CentralNotice --></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> <div class="vector-sticky-pinned-container"> <nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark"> <div id="vector-toc-pinned-container" class="vector-pinned-container"> <div id="vector-toc" class="vector-toc vector-pinnable-element"> <div class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned" data-feature-name="toc-pinned" data-pinnable-element-id="vector-toc" > <h2 class="vector-pinnable-header-label">Contents</h2> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button> </div> <ul class="vector-toc-contents" id="mw-panel-toc-list"> <li id="toc-mw-content-text" class="vector-toc-list-item vector-toc-level-1"> <a href="#" class="vector-toc-link"> <div class="vector-toc-text">(Top)</div> </a> </li> <li id="toc-Medical_uses" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Medical_uses"> <div class="vector-toc-text"> <span class="vector-toc-numb">1</span> <span>Medical uses</span> </div> </a> <ul id="toc-Medical_uses-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Contraindications" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Contraindications"> <div class="vector-toc-text"> <span class="vector-toc-numb">2</span> <span>Contraindications</span> </div> </a> <ul id="toc-Contraindications-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Side_effects" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Side_effects"> <div class="vector-toc-text"> <span class="vector-toc-numb">3</span> <span>Side effects</span> </div> </a> <ul id="toc-Side_effects-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Interactions" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Interactions"> <div class="vector-toc-text"> <span class="vector-toc-numb">4</span> <span>Interactions</span> </div> </a> <ul id="toc-Interactions-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pharmacology" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Pharmacology"> <div class="vector-toc-text"> <span class="vector-toc-numb">5</span> <span>Pharmacology</span> </div> </a> <button aria-controls="toc-Pharmacology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Pharmacology subsection</span> </button> <ul id="toc-Pharmacology-sublist" class="vector-toc-list"> <li id="toc-Mechanism_of_action" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Mechanism_of_action"> <div class="vector-toc-text"> <span class="vector-toc-numb">5.1</span> <span>Mechanism of action</span> </div> </a> <ul id="toc-Mechanism_of_action-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Pharmacokinetics" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Pharmacokinetics"> <div class="vector-toc-text"> <span class="vector-toc-numb">5.2</span> <span>Pharmacokinetics</span> </div> </a> <ul id="toc-Pharmacokinetics-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-History" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#History"> <div class="vector-toc-text"> <span class="vector-toc-numb">6</span> <span>History</span> </div> </a> <ul id="toc-History-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Society_and_culture" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Society_and_culture"> <div class="vector-toc-text"> <span class="vector-toc-numb">7</span> <span>Society and culture</span> </div> </a> <button aria-controls="toc-Society_and_culture-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Society and culture subsection</span> </button> <ul id="toc-Society_and_culture-sublist" class="vector-toc-list"> <li id="toc-Legal_status" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#Legal_status"> <div class="vector-toc-text"> <span class="vector-toc-numb">7.1</span> <span>Legal status</span> </div> </a> <ul id="toc-Legal_status-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-Research" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Research"> <div class="vector-toc-text"> <span class="vector-toc-numb">8</span> <span>Research</span> </div> </a> <button aria-controls="toc-Research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle"> <span class="vector-icon mw-ui-icon-wikimedia-expand"></span> <span>Toggle Research subsection</span> </button> <ul id="toc-Research-sublist" class="vector-toc-list"> <li id="toc-COVID-19" class="vector-toc-list-item vector-toc-level-2"> <a class="vector-toc-link" href="#COVID-19"> <div class="vector-toc-text"> <span class="vector-toc-numb">8.1</span> <span>COVID-19</span> </div> </a> <ul id="toc-COVID-19-sublist" class="vector-toc-list"> </ul> </li> </ul> </li> <li id="toc-References" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#References"> <div class="vector-toc-text"> <span class="vector-toc-numb">9</span> <span>References</span> </div> </a> <ul id="toc-References-sublist" class="vector-toc-list"> </ul> </li> <li id="toc-Further_reading" class="vector-toc-list-item vector-toc-level-1 vector-toc-list-item-expanded"> <a class="vector-toc-link" href="#Further_reading"> <div class="vector-toc-text"> <span class="vector-toc-numb">10</span> <span>Further reading</span> </div> </a> <ul id="toc-Further_reading-sublist" class="vector-toc-list"> </ul> </li> </ul> </div> </div> </nav> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <nav aria-label="Contents" class="vector-toc-landmark"> <div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left" > <input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox " aria-label="Toggle the table of contents" > <label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span> <span class="vector-dropdown-label-text">Toggle the table of contents</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Baricitinib</span></h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 17 languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-17" aria-hidden="true" ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span> <span class="vector-dropdown-label-text">17 languages</span> </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%A8%D8%A7%D8%B1%D9%8A%D8%B3%D9%8A%D8%AA%D9%8A%D9%86%D8%A8" title="باريسيتينب – Arabic" lang="ar" hreflang="ar" data-title="باريسيتينب" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Catalan" lang="ca" hreflang="ca" data-title="Baricitinib" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Baricitinib" title="Baricitinib – German" lang="de" hreflang="de" data-title="Baricitinib" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Spanish" lang="es" hreflang="es" data-title="Baricitinib" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A8%D8%A7%D8%B1%DB%8C%D8%B3%DB%8C%D8%AA%DB%8C%D9%86%DB%8C%D8%A8" title="باریسیتینیب – Persian" lang="fa" hreflang="fa" data-title="باریسیتینیب" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Baricitinib" title="Baricitinib – French" lang="fr" hreflang="fr" data-title="Baricitinib" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Italian" lang="it" hreflang="it" data-title="Baricitinib" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%91%D7%A8%D7%99%D7%A6%D7%99%D7%98%D7%99%D7%A0%D7%99%D7%91" title="בריציטיניב – Hebrew" lang="he" hreflang="he" data-title="בריציטיניב" data-language-autonym="עברית" data-language-local-name="Hebrew" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E3%83%90%E3%83%AA%E3%82%B7%E3%83%81%E3%83%8B%E3%83%96" title="バリシチニブ – Japanese" lang="ja" hreflang="ja" data-title="バリシチニブ" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%AC%E0%AC%BE%E0%AC%B0%E0%AC%BF%E0%AC%B8%E0%AC%BF%E0%AC%9F%E0%AC%BF%E0%AC%A8%E0%AC%BF%E0%AC%AC" title="ବାରିସିଟିନିବ – Odia" lang="or" hreflang="or" data-title="ବାରିସିଟିନିବ" data-language-autonym="ଓଡ଼ିଆ" data-language-local-name="Odia" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Baricitinibe" title="Baricitinibe – Portuguese" lang="pt" hreflang="pt" data-title="Baricitinibe" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Romanian" lang="ro" hreflang="ro" data-title="Baricitinib" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%91%D0%B0%D1%80%D0%B8%D1%86%D0%B8%D1%82%D0%B8%D0%BD%D0%B8%D0%B1" title="Барицитиниб – Russian" lang="ru" hreflang="ru" data-title="Барицитиниб" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Serbian" lang="sr" hreflang="sr" data-title="Baricitinib" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Baricitinib" title="Baricitinib – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Baricitinib" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%91%D0%B0%D1%80%D1%96%D1%86%D0%B8%D1%82%D0%B8%D0%BD%D1%96%D0%B1" title="Баріцитиніб – Ukrainian" lang="uk" hreflang="uk" data-title="Баріцитиніб" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E5%B7%B4%E7%91%9E%E6%9B%BF%E5%B0%BC" title="巴瑞替尼 – Chinese" lang="zh" hreflang="zh" data-title="巴瑞替尼" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target"><span>中文</span></a></li> </ul> <div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q4860707#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Baricitinib" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Baricitinib" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">English</span> </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Baricitinib"><span>Read</span></a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">Tools</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Baricitinib"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;action=history"><span>View history</span></a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Baricitinib" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Baricitinib" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;oldid=1258014091" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Baricitinib&amp;id=1258014091&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FBaricitinib"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FBaricitinib"><span>Download QR code</span></a></li> </ul> </div> </div> <div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export" > <div class="vector-menu-heading"> Print/export </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Baricitinib&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Baricitinib&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Baricitinib" hreflang="en"><span>Wikimedia Commons</span></a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q4860707" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> <div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div> </div> <div id="contentSub"><div id="mw-content-subtitle"></div></div> <div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Chemical compound</div> <p class="mw-empty-elt"> </p> <style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><table class="infobox" style="border-spacing:2px;"><caption class="infobox-title"><span title="International nonproprietary name (INN): Baricitinib">Baricitinib</span></caption><tbody><tr><td colspan="2" class="infobox-image notheme" style="background-color: #f8f9fa;"><table style="width:100%; margin:0;"><tbody><tr> <td style="vertical-align:top; text-align:center; width:50%;"><span typeof="mw:File"><a href="/wiki/File:Baricitinib_structure.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/140px-Baricitinib_structure.svg.png" decoding="async" width="140" height="221" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/210px-Baricitinib_structure.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Baricitinib_structure.svg/280px-Baricitinib_structure.svg.png 2x" data-file-width="512" data-file-height="809" /></a></span></td> <td style="vertical-align:top; text-align:center; width:50%;"><span typeof="mw:File"><a href="/wiki/File:Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png/140px-Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png" decoding="async" width="140" height="223" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png/210px-Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/94/Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png/280px-Baricitinib-portrait-ligand-3JW-from-PDB-xtal-4W9X-Mercury-3D-balls.png 2x" data-file-width="1257" data-file-height="2000" /></a></span></td> </tr></tbody></table></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Clinical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_nomenclature#Trade_names" title="Drug nomenclature">Trade names</a></th><td class="infobox-data">Olumiant, others</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">Other names</th><td class="infobox-data">INCB28050, LY3009104</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th><td class="infobox-data"><span title="www.drugs.com"><a rel="nofollow" class="external text" href="https://www.drugs.com/monograph/baricitinib.html">Monograph</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th><td class="infobox-data"><span title="medlineplus.gov"><a rel="nofollow" class="external text" href="https://medlineplus.gov/druginfo/meds/a618033.html">a618033</a></span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">License data</a></th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"> <ul><li><small><abbr class="country-name" title="United States">US</abbr></small>&#160;<a href="/wiki/DailyMed" title="DailyMed">DailyMed</a>:&#160;<span title="dailymed.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=Baricitinib">Baricitinib</a></span></li></ul></div> </td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy<br />category</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"> <ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small>&#x20;D<sup id="cite_ref-Olumiant_AU_PI_1-0" class="reference"><a href="#cite_note-Olumiant_AU_PI-1"><span class="cite-bracket">&#91;</span>1<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Drugs.com_pregnancy_2-0" class="reference"><a href="#cite_note-Drugs.com_pregnancy-2"><span class="cite-bracket">&#91;</span>2<span class="cite-bracket">&#93;</span></a></sup></li> <li>Use is contraindicated</li></ul> </div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes of<br />administration</a></th><td class="infobox-data"><a href="/wiki/Oral_administration" title="Oral administration">By mouth</a></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><a href="/wiki/ATC_code_L04" title="ATC code L04">L04AF02</a>&#x20;(<span title="www.whocc.no"><a rel="nofollow" class="external text" href="https://www.whocc.no/atc_ddd_index/?code=L04AF02">WHO</a></span>)&#x20;</li></ul></div></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Legal status</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"> <ul><li><small><abbr class="country-name" title="Australia">AU</abbr>:</small>&#x20;<a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons#Schedule_4" title="Standard for the Uniform Scheduling of Medicines and Poisons">S4</a> (Prescription only)<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span class="cite-bracket">&#91;</span>4<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Olumiant_AU_PI_1-1" class="reference"><a href="#cite_note-Olumiant_AU_PI-1"><span class="cite-bracket">&#91;</span>1<span class="cite-bracket">&#93;</span></a></sup></li> <li><small><abbr class="country-name" title="Canada">CA</abbr></small>:&#x20;<a href="/wiki/Prescription_drug" title="Prescription drug"> ℞-only</a><sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span class="cite-bracket">&#91;</span>5<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span class="cite-bracket">&#91;</span>6<span class="cite-bracket">&#93;</span></a></sup></li> <li><small><abbr class="country-name" title="United States">US</abbr>:</small>&#x20;<a href="/wiki/Boxed_warning" title="Boxed warning"><span style="border:thin solid black;">WARNING</span></a><sup id="cite_ref-FDA-AllBoxedWarnings_3-0" class="reference"><a href="#cite_note-FDA-AllBoxedWarnings-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup>Rx-only<sup id="cite_ref-Olumiant_FDA_label_7-0" class="reference"><a href="#cite_note-Olumiant_FDA_label-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup></li> <li><small><abbr class="country-name" title="European Union">EU</abbr>:</small>&#x20;Rx-only<sup id="cite_ref-Olumiant_EPAR_8-0" class="reference"><a href="#cite_note-Olumiant_EPAR-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup></li> <li>In&#160;general: ℞&#160;(Prescription only)</li></ul></div> </td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetic</a> data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th><td class="infobox-data">79%</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th><td class="infobox-data">50%</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th><td class="infobox-data"><a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a> (&lt;10%)</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Biological_half-life" title="Biological half-life">Elimination <span class="nowrap">half-life</span></a></th><td class="infobox-data">12.5 hours</td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></th><td class="infobox-data">75% urine, 20% faeces</td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Identifiers</th></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/IUPAC_nomenclature_of_chemistry" title="IUPAC nomenclature of chemistry">IUPAC name</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em;"><li style="line-height: inherit; margin: 0"><div style="font-size: 97%;">2-[1-Ethylsulfonyl-3-[4-(7<i>H</i>-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile</div></li></ul> </div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CAS_Registry_Number" title="CAS Registry Number">CAS Number</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="commonchemistry.cas.org"><a rel="nofollow" class="external text" href="https://commonchemistry.cas.org/detail?cas_rn=1187594-09-7">1187594-09-7</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/PubChem#CID" title="PubChem">PubChem</a> <span style="font-weight:normal"><abbr title="Compound ID">CID</abbr></span></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="pubchem.ncbi.nlm.nih.gov"><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/compound/44205240">44205240</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.drugbank.ca"><a rel="nofollow" class="external text" href="https://www.drugbank.ca/drugs/DB11817">DB11817</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.chemspider.com"><a rel="nofollow" class="external text" href="https://www.chemspider.com/Chemical-Structure.26373084.html">26373084</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="precision.fda.gov"><a rel="nofollow" class="external text" href="https://precision.fda.gov/uniisearch/srs/unii/ISP4442I3Y">ISP4442I3Y</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/KEGG" title="KEGG">KEGG</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.kegg.jp"><a rel="nofollow" class="external text" href="https://www.kegg.jp/entry/D10308">D10308</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:95341">CHEBI:95341</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembl/explore/compound/ChEMBL2105759">ChEMBL2105759</a></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB ligand</a></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li>3JW (<span title="www.ebi.ac.uk"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=3JW">PDBe</a></span>, <span title="www.rcsb.org"><a rel="nofollow" class="external text" href="https://www.rcsb.org/ligand/3JW">RCSB&#160;PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/CompTox_Chemicals_Dashboard" title="CompTox Chemicals Dashboard">CompTox Dashboard</a> <span style="font-weight:normal">(<abbr title="U.S. Environmental Protection Agency">EPA</abbr>)</span></th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="comptox.epa.gov"><a rel="nofollow" class="external text" href="https://comptox.epa.gov/dashboard/chemical/details/DTXSID30152228">DTXSID30152228</a> <span class="mw-valign-text-top noprint" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q4860707#P3117" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></span></li></ul></div></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/ECHA_InfoCard" class="mw-redirect" title="ECHA InfoCard"><span title="echa.europa.eu">ECHA InfoCard</span></a></th><td class="infobox-data"><a rel="nofollow" class="external text" href="https://echa.europa.eu/substance-information/-/substanceinfo/100.219.080">100.219.080</a> <span class="mw-valign-text-top noprint" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q4860707#P2566" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></td></tr><tr><th colspan="2" class="infobox-header" style="background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th><td class="infobox-data"><span title="Carbon">C</span><sub>16</sub><span title="Hydrogen">H</span><sub>17</sub><span title="Nitrogen">N</span><sub>7</sub><span title="Oxygen">O</span><sub>2</sub><span title="Sulfur">S</span></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;"><a href="/wiki/Molar_mass" title="Molar mass">Molar mass</a></th><td class="infobox-data"><span class="nowrap"><span data-sort-value="7002371420000000000♠"></span>371.42</span>&#160;g·mol<sup>−1</sup></td></tr><tr><th scope="row" class="infobox-label" style="line-height:1.2em;">3D model (<a href="/wiki/JSmol" class="mw-redirect" title="JSmol">JSmol</a>)</th><td class="infobox-data"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409"><div class="plainlist"><ul><li><span title="chemapps.stolaf.edu (3D interactive model)"><a rel="nofollow" class="external text" href="https://chemapps.stolaf.edu/jmol/jmol.php?model=CCS%28%3DO%29%28%3DO%29N1CC%28CC%23N%29%28n2cc%28-c3ncnc4%5BnH%5Dccc34%29cn2%29C1">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/Simplified_molecular-input_line-entry_system" class="mw-redirect" title="Simplified molecular-input line-entry system">SMILES</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1</div></li></ul> </div></td></tr><tr><td colspan="2" class="infobox-full-data"><div class="collapsible-list mw-collapsible mw-collapsed" style="text-align: left;"> <div style="line-height: 1.6em; font-weight: bold;"><div><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div></div> <ul class="mw-collapsible-content" style="margin-top: 0; margin-bottom: 0; line-height: inherit; list-style: none; margin-left: 0; word-break:break-all;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)</div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:97%; line-height:120%;">Key:XUZMWHLSFXCVMG-UHFFFAOYSA-N</div></li></ul> </div></td></tr></tbody></table> <p><b>Baricitinib</b>, sold under the brand name <b>Olumiant</b> among others, is an <a href="/wiki/Immunomodulatory" class="mw-redirect" title="Immunomodulatory">immunomodulatory</a> <a href="/wiki/Medication" title="Medication">medication</a> used for the treatment of <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/wiki/Alopecia_areata" title="Alopecia areata">alopecia areata</a>, and <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>.<sup id="cite_ref-Olumiant_FDA_label_7-1" class="reference"><a href="#cite_note-Olumiant_FDA_label-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Olumiant_EPAR_8-1" class="reference"><a href="#cite_note-Olumiant_EPAR-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_snapshot_9-0" class="reference"><a href="#cite_note-FDA_snapshot-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20220613_10-0" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> It acts as an <a href="/wiki/Janus_kinase_inhibitor" title="Janus kinase inhibitor">inhibitor of janus kinase</a> (JAK), blocking the subtypes <a href="/wiki/JAK1" class="mw-redirect" title="JAK1">JAK1</a> and <a href="/wiki/JAK2" class="mw-redirect" title="JAK2">JAK2</a>.<sup id="cite_ref-CHMP_11-0" class="reference"><a href="#cite_note-CHMP-11"><span class="cite-bracket">&#91;</span>11<span class="cite-bracket">&#93;</span></a></sup> </p><p>Baricitinib is approved for medical use in the European Union<sup id="cite_ref-Olumiant_EPAR_8-2" class="reference"><a href="#cite_note-Olumiant_EPAR-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup> and in the United States.<sup id="cite_ref-FDA_snapshot_9-1" class="reference"><a href="#cite_note-FDA_snapshot-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_approval_12-0" class="reference"><a href="#cite_note-FDA_approval-12"><span class="cite-bracket">&#91;</span>12<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20220613_10-1" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> </p> <meta property="mw:PageProp/toc" /> <div class="mw-heading mw-heading2"><h2 id="Medical_uses">Medical uses</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=1" title="Edit section: Medical uses"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In February 2017, baricitinib was approved for use in the European Union as a second-line therapy for moderate to severe active rheumatoid arthritis in adults, either alone or in combination with <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>.<sup id="cite_ref-EMA_13-0" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Olumiant_EPAR_8-3" class="reference"><a href="#cite_note-Olumiant_EPAR-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup> </p><p>In May 2018, the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) approved baricitinib for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.<sup id="cite_ref-FDA_approval_12-1" class="reference"><a href="#cite_note-FDA_approval-12"><span class="cite-bracket">&#91;</span>12<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_snapshot_9-2" class="reference"><a href="#cite_note-FDA_snapshot-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Olumiant_FDA_label_7-2" class="reference"><a href="#cite_note-Olumiant_FDA_label-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup> </p><p>In May 2022, the FDA approved baricitinib for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).<sup id="cite_ref-Olumiant_FDA_label_7-3" class="reference"><a href="#cite_note-Olumiant_FDA_label-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_FAQ_14-0" class="reference"><a href="#cite_note-FDA_FAQ-14"><span class="cite-bracket">&#91;</span>14<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20220510_15-0" class="reference"><a href="#cite_note-FDA_PR_20220510-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup> Baricitinib is the first immunomodulatory treatment for COVID-19 to receive FDA approval.<sup id="cite_ref-FDA_PR_20220510_15-1" class="reference"><a href="#cite_note-FDA_PR_20220510-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup> </p><p>In the United States, baricitinib is authorized under an <a href="/wiki/Emergency_use_authorization" class="mw-redirect" title="Emergency use authorization">emergency use authorization</a> (EUA) for the treatment of COVID-19 in hospitalized people aged 2 to less than 18 years of age who require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.<sup id="cite_ref-FDA_FAQ_14-1" class="reference"><a href="#cite_note-FDA_FAQ-14"><span class="cite-bracket">&#91;</span>14<span class="cite-bracket">&#93;</span></a></sup> </p><p>In June 2022, the FDA authorized baricitinib for the treatment of severe alopecia areata.<sup id="cite_ref-FDA_PR_20220613_10-2" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Lilly_PR_20220613_16-0" class="reference"><a href="#cite_note-Lilly_PR_20220613-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Contraindications">Contraindications</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=2" title="Edit section: Contraindications"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>During pregnancy, the use of baricitinib is contraindicated.<sup id="cite_ref-Drugs.com_pregnancy_2-1" class="reference"><a href="#cite_note-Drugs.com_pregnancy-2"><span class="cite-bracket">&#91;</span>2<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-EMA_13-1" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Side_effects">Side effects</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=3" title="Edit section: Side effects"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In studies, <a href="/wiki/Upper_respiratory_tract_infection" title="Upper respiratory tract infection">upper respiratory tract infections</a> and high blood <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> levels (<a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>) occurred in more than 10% of participants. Less common side effects included other infections such as <a href="/wiki/Herpes_zoster" class="mw-redirect" title="Herpes zoster">herpes zoster</a>, <a href="/wiki/Herpes_simplex" class="mw-redirect" title="Herpes simplex">herpes simplex</a>, <a href="/wiki/Urinary_tract_infection" title="Urinary tract infection">urinary tract infections</a>, and <a href="/wiki/Gastroenteritis" title="Gastroenteritis">gastroenteritis</a>.<sup id="cite_ref-EMA_13-2" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Interactions">Interactions</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=4" title="Edit section: Interactions"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Being <a href="/wiki/Metabolized" class="mw-redirect" title="Metabolized">metabolized</a> only to a small extent, the substance has a low potential for interactions. In studies, inhibitors of the liver enzymes <a href="/wiki/CYP3A4" title="CYP3A4">CYP3A4</a>, <a href="/wiki/CYP2C19" title="CYP2C19">CYP2C19</a>, and <a href="/wiki/CYP2C9" title="CYP2C9">CYP2C9</a>, as well as the CYP3A4 <a href="/wiki/Enzyme_inducer" title="Enzyme inducer">inducer</a> <a href="/wiki/Rifampicin" title="Rifampicin">rifampicin</a>, had no relevant influence on baricitinib concentrations in the bloodstream. While baricitinib blocks a number of <a href="/wiki/Transporter_protein" class="mw-redirect" title="Transporter protein">transporter proteins</a> <i><a href="/wiki/In_vitro" title="In vitro">in vitro</a></i>, clinically relevant interactions via this mechanism are considered very unlikely, except perhaps for the cation transporter <a href="/wiki/SLC22A1" title="SLC22A1">SLC22A1</a> (OCT1).<sup id="cite_ref-EMA_13-3" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p><p>An additive effect with other <a href="/wiki/Immunosuppressant" class="mw-redirect" title="Immunosuppressant">immunosuppressants</a> cannot be excluded.<sup id="cite_ref-EMA_13-4" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Pharmacology">Pharmacology</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=5" title="Edit section: Pharmacology"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Mechanism_of_action">Mechanism of action</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=6" title="Edit section: Mechanism of action"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Janus_kinase_inhibitor#Mechanism_of_action" title="Janus kinase inhibitor">Janus kinase inhibitor §&#160;Mechanism of action</a></div> <p>Baricitinib is a Janus kinase (JAK) inhibitor that reversibly inhibits <a href="/wiki/Janus_kinase_1" title="Janus kinase 1">Janus kinase 1</a> with a <a href="/wiki/Half_maximal_inhibitory_concentration" class="mw-redirect" title="Half maximal inhibitory concentration">half maximal inhibitory concentration</a> (IC<sub>50</sub>) of 5.9&#160;<a href="/wiki/Nanomolar" class="mw-redirect" title="Nanomolar">nM</a> and <a href="/wiki/Janus_kinase_2" title="Janus kinase 2">Janus kinase 2</a> with an IC<sub>50</sub> of 5.7&#160;nM. <a href="/wiki/Tyrosine_kinase_2" title="Tyrosine kinase 2">Tyrosine kinase 2</a>, which belongs to the same enzyme family, is affected less (IC<sub>50</sub> = 53&#160;nM), and <a href="/wiki/Janus_kinase_3" title="Janus kinase 3">Janus kinase 3</a> far less (IC<sub>50</sub> &gt; 400&#160;nM). Via a <a href="/wiki/Signal_transduction" title="Signal transduction">signal transduction</a> pathway involving <a href="/wiki/STAT_protein" title="STAT protein">STAT proteins</a>, this ultimately modulates <a href="/wiki/Gene_expression" title="Gene expression">gene expression</a> in immunological cells.<sup id="cite_ref-EMA_13-5" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p><p>Other JAK inhibitors include <a href="/wiki/Tofacitinib" title="Tofacitinib">tofacitinib</a>, which is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis;<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span class="cite-bracket">&#91;</span>17<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-November2012_18-0" class="reference"><a href="#cite_note-November2012-18"><span class="cite-bracket">&#91;</span>18<span class="cite-bracket">&#93;</span></a></sup> <a href="/wiki/Fedratinib" title="Fedratinib">fedratinib</a>,<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span class="cite-bracket">&#91;</span>19<span class="cite-bracket">&#93;</span></a></sup> and <a href="/wiki/Ruxolitinib" title="Ruxolitinib">ruxolitinib</a>.<sup id="cite_ref-Mesa2010_20-0" class="reference"><a href="#cite_note-Mesa2010-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span class="cite-bracket">&#91;</span>21<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="Pharmacokinetics">Pharmacokinetics</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=7" title="Edit section: Pharmacokinetics"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>The substance is quickly absorbed from the gut with an absolute <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of 79%. It reaches highest <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> levels after about an hour; in different individuals the time to reach this level ranges from 0.5 to 3 hours. Food intake has no relevant influence on the drug's pharmacokinetics. 50% of the circulating baricitinib are bound to blood <a href="/wiki/Plasma_protein" title="Plasma protein">plasma proteins</a>.<sup id="cite_ref-EMA_13-6" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p><p>Less than 10% of the substance is metabolized to four different oxidation products by CYP3A4; the rest is left unchanged. <a href="/wiki/Elimination_half-life" class="mw-redirect" title="Elimination half-life">Elimination half-life</a> is 12.5 hours on average. About 75% is eliminated via the urine, and 20% via the <a href="/wiki/Faeces" class="mw-redirect" title="Faeces">faeces</a>.<sup id="cite_ref-EMA_13-7" class="reference"><a href="#cite_note-EMA-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="History">History</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=8" title="Edit section: History"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>Baricitinib was discovered by <a href="/wiki/Incyte" title="Incyte">Incyte</a> and licensed to <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly</a>.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span class="cite-bracket">&#91;</span>22<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Society_and_culture">Society and culture</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=9" title="Edit section: Society and culture"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <div class="mw-heading mw-heading3"><h3 id="Legal_status">Legal status</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=10" title="Edit section: Legal status"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>In January 2016, Eli Lilly submitted a <a href="/wiki/New_drug_application" class="mw-redirect" title="New drug application">new drug application</a> to the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) for the approval of baricitinib to treat moderately-to-severely active rheumatoid arthritis.<sup id="cite_ref-NDA_23-0" class="reference"><a href="#cite_note-NDA-23"><span class="cite-bracket">&#91;</span>23<span class="cite-bracket">&#93;</span></a></sup> </p><p>In December 2016, the <a href="/wiki/Committee_for_Medicinal_Products_for_Human_Use" title="Committee for Medicinal Products for Human Use">Committee for Medicinal Products for Human Use</a> (CHMP) of the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA) recommended the approval of baricitinib as a therapy for rheumatoid arthritis.<sup id="cite_ref-CHMP_11-1" class="reference"><a href="#cite_note-CHMP-11"><span class="cite-bracket">&#91;</span>11<span class="cite-bracket">&#93;</span></a></sup> European Union approval was granted in February 2017.<sup id="cite_ref-Olumiant_EPAR_8-4" class="reference"><a href="#cite_note-Olumiant_EPAR-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup> </p><p>Despite widespread expectations that the FDA would approve baricitinib for rheumatoid arthritis,<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span class="cite-bracket">&#91;</span>24<span class="cite-bracket">&#93;</span></a></sup> in April 2017, the FDA issued a rejection, citing concerns about dosing and safety.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span class="cite-bracket">&#91;</span>25<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span class="cite-bracket">&#91;</span>26<span class="cite-bracket">&#93;</span></a></sup> </p><p>In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis.<sup id="cite_ref-FDA_snapshot_9-3" class="reference"><a href="#cite_note-FDA_snapshot-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_approval_12-2" class="reference"><a href="#cite_note-FDA_approval-12"><span class="cite-bracket">&#91;</span>12<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20220613_10-3" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> </p><p>In March 2020, the US FDA granted <a href="/wiki/Breakthrough_therapy" title="Breakthrough therapy">breakthrough therapy</a> designation to baricitinib for the treatment of <a href="/wiki/Alopecia_areata" title="Alopecia areata">alopecia areata</a><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span class="cite-bracket">&#91;</span>27<span class="cite-bracket">&#93;</span></a></sup> and granted approval in June 2022.<sup id="cite_ref-Lilly_PR_20220613_16-1" class="reference"><a href="#cite_note-Lilly_PR_20220613-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup> </p><p>The efficacy and safety of baricitinib in alopecia areata was studied in two randomized, double-blind, placebo-controlled trials (Trial AA-1 and Trial AA-2) with participants who had at least 50% scalp hair loss as measured by the Severity of Alopecia Tool for more than six months.<sup id="cite_ref-FDA_PR_20220613_10-4" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> Participants in these trials received either a placebo, 2 milligrams of baricitinib, or 4 milligrams of baricitinib every day.<sup id="cite_ref-FDA_PR_20220613_10-5" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> The primary measurement of efficacy for both trials was the proportion of participants who achieved at least 80% scalp hair coverage at week 36.<sup id="cite_ref-FDA_PR_20220613_10-6" class="reference"><a href="#cite_note-FDA_PR_20220613-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="Research">Research</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=11" title="Edit section: Research"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p>As of August&#160;2016<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Baricitinib&amp;action=edit">&#91;update&#93;</a></sup>, 31 clinical trials had been registered for baricitinib of which 24 had completed,<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span class="cite-bracket">&#91;</span>28<span class="cite-bracket">&#93;</span></a></sup> and 4 of 6 phase 3 trials had completed.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span class="cite-bracket">&#91;</span>29<span class="cite-bracket">&#93;</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Manual_of_Style/Dates_and_numbers#Chronological_items" title="Wikipedia:Manual of Style/Dates and numbers"><span title="The date of the event predicted near this tag has passed. (April 2020)">needs update</span></a></i>&#93;</sup> </p><p>As of March&#160;2022<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Baricitinib&amp;action=edit">&#91;update&#93;</a></sup>, a phase III clinical trial showed hair regrowth for those with <a href="/wiki/Alopecia_areata" title="Alopecia areata">alopecia areata</a>.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span class="cite-bracket">&#91;</span>30<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading3"><h3 id="COVID-19">COVID-19</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=12" title="Edit section: COVID-19"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <p><span class="anchor" id="COVID-19_research"></span> </p><p>In April 2020, Lilly announced they were investigating the use of baricitinib for treating people with <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>. The drug's anti-inflammatory activity was expected to act on the inflammatory cascade associated with COVID-19.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span class="cite-bracket">&#91;</span>31<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> </p><p>In April and June 2020, the first two studies of baricitinib prescribed for hospitalized people with COVID-19 were published online.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span class="cite-bracket">&#91;</span>34<span class="cite-bracket">&#93;</span></a></sup> Then in November 2020, published research showed baricitinib was beneficial in treating people with COVID-19. According to the paper "mechanistic actions of a Janus kinase-1/2 inhibitor targeting viral entry, replication and the <a href="/wiki/Cytokine_storm" title="Cytokine storm">cytokine storm</a>, and is associated with beneficial outcomes including in severely ill elderly people".<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span class="cite-bracket">&#91;</span>35<span class="cite-bracket">&#93;</span></a></sup> </p><p>In a clinical trial of hospitalized people with COVID-19, baricitinib, in combination with remdesivir, was shown to reduce time to recovery within 29 days after initiating treatment compared to participants who received a placebo with remdesivir.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span class="cite-bracket">&#91;</span>36<span class="cite-bracket">&#93;</span></a></sup> </p><p>The data supporting the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) <a href="/wiki/Emergency_use_authorization" class="mw-redirect" title="Emergency use authorization">emergency use authorization</a> (EUA) for baricitinib combined with remdesivir was based on a randomized, double-blind, placebo-controlled clinical trial (ACTT-2), which was conducted by the US <a href="/wiki/National_Institute_of_Allergy_and_Infectious_Diseases" title="National Institute of Allergy and Infectious Diseases">National Institute of Allergy and Infectious Diseases</a> (NIAID).<sup id="cite_ref-FDA_PR_20201119_37-0" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_CDER_Review_38-0" class="reference"><a href="#cite_note-FDA_CDER_Review-38"><span class="cite-bracket">&#91;</span>38<span class="cite-bracket">&#93;</span></a></sup> This clinical trial evaluated whether baricitinib impacted how long it took for subjects who were also taking remdesivir to recover from COVID-19.<sup id="cite_ref-FDA_PR_20201119_37-1" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> The trial followed participants for 29 days and included 1,033 participants with moderate or severe COVID-19; 515 participants received baricitinib plus remdesivir, and 518 participants received placebo plus remdesivir.<sup id="cite_ref-FDA_PR_20201119_37-2" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> Recovery was defined as either being discharged from the hospital or being hospitalized but not requiring supplemental oxygen and no longer requiring ongoing medical care.<sup id="cite_ref-FDA_PR_20201119_37-3" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> The median time to recovery from COVID-19 was seven days for baricitinib plus remdesivir and eight days for placebo plus remdesivir.<sup id="cite_ref-FDA_PR_20201119_37-4" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> The odds of a patient's condition progressing to death or being ventilated at day 29 was 31% lower in the baricitinib plus remdesivir group versus the placebo plus remdesivir group.<sup id="cite_ref-FDA_PR_20201119_37-5" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> The odds of clinical improvement at day 15 was 30% higher in the baricitinib plus remdesivir group versus the placebo plus remdesivir group.<sup id="cite_ref-FDA_PR_20201119_37-6" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> For all of these endpoints, the effects were statistically significant.<sup id="cite_ref-FDA_PR_20201119_37-7" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> The EUA was issued to <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a>.<sup id="cite_ref-FDA_PR_20201119_37-8" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> </p><p>In November 2020, the World Health Organization (WHO) updated its guideline on therapeutics for COVID-19 to include a conditional recommendation against the use of remdesivir, triggered by results from the WHO <a href="/wiki/Solidarity_trial" title="Solidarity trial">Solidarity trial</a>.<sup id="cite_ref-WHO_guidelines_39-0" class="reference"><a href="#cite_note-WHO_guidelines-39"><span class="cite-bracket">&#91;</span>39<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-who-lg_40-0" class="reference"><a href="#cite_note-who-lg-40"><span class="cite-bracket">&#91;</span>40<span class="cite-bracket">&#93;</span></a></sup> </p><p>In November 2020, the FDA issued an <a href="/wiki/Emergency_use_authorization" class="mw-redirect" title="Emergency use authorization">emergency use authorization</a> (EUA) for the combination of baricitinib with <a href="/wiki/Remdesivir" title="Remdesivir">remdesivir</a>, for the treatment of suspected or laboratory confirmed <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a> in hospitalized people aged two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or <a href="/wiki/Extracorporeal_membrane_oxygenation" title="Extracorporeal membrane oxygenation">extracorporeal membrane oxygenation</a> (ECMO).<sup id="cite_ref-FDA_EUA_41-0" class="reference"><a href="#cite_note-FDA_EUA-41"><span class="cite-bracket">&#91;</span>41<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_EUA_Fact_Sheet_42-0" class="reference"><a href="#cite_note-FDA_EUA_Fact_Sheet-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20201119_37-9" class="reference"><a href="#cite_note-FDA_PR_20201119-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> </p><p>Then in September 2021, the largest randomized, placebo-controlled trial of hospitalized people with COVID-19 to date, COV-BARRIER, was published.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span class="cite-bracket">&#91;</span>43<span class="cite-bracket">&#93;</span></a></sup> This trial randomized 1525 participants to either baricitinib or placebo. Nearly 80% of participants were receiving systemic corticosteroids at enrollment. There was an absolute risk reduction of 2.7 percent in the primary endpoint of progression to high-flow oxygen, non-invasive ventilation, invasive mechanical ventilation, or death by day 28. The 38.2% statistically significant reduction in all-cause 28-day mortality for participants receiving baricitinib compared to placebo was the largest mortality reduction to date and maintained at 60 days. This translates into one additional death prevented for every 20 participants treated with baricitinib. The frequencies of serious adverse events were lower for participants receiving baricitinib compared to those receiving placebo.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2022)">citation needed</span></a></i>&#93;</sup> </p><p>As of April&#160;2021<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Baricitinib&amp;action=edit">&#91;update&#93;</a></sup>, the <a href="/wiki/Committee_for_Medicinal_Products_for_Human_Use" title="Committee for Medicinal Products for Human Use">Committee for Medicinal Products for Human Use</a> (CHMP) of the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA) is evaluating the use of baricitinib to include treatment of COVID-19 in hospitalized people from ten years of age who require supplemental oxygen.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span class="cite-bracket">&#91;</span>44<span class="cite-bracket">&#93;</span></a></sup> </p><p>In July 2021, the FDA revised the EUA for baricitinib authorizing it alone for the treatment of COVID-19 in hospitalized people aged two years of age or older requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).<sup id="cite_ref-FDA_EUA_41-1" class="reference"><a href="#cite_note-FDA_EUA-41"><span class="cite-bracket">&#91;</span>41<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_EUA_Fact_Sheet_42-1" class="reference"><a href="#cite_note-FDA_EUA_Fact_Sheet-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_PR_20210730_45-0" class="reference"><a href="#cite_note-FDA_PR_20210730-45"><span class="cite-bracket">&#91;</span>45<span class="cite-bracket">&#93;</span></a></sup> Under the revised EUA, baricitinib is not required to be administered with remdesivir.<sup id="cite_ref-FDA_PR_20210730_45-1" class="reference"><a href="#cite_note-FDA_PR_20210730-45"><span class="cite-bracket">&#91;</span>45<span class="cite-bracket">&#93;</span></a></sup> </p><p>As of January 2022, the World Health Organization recommends baricitinib for people with severe or critical COVID-19.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup> Thereafter in February 2022, an exploratory randomized, placebo-controlled trial of participants receiving invasive mechanical ventilation or extracorporeal membrane oxygenation were randomly to baricitinib or placebo. There was a 46% statistically significant relative reduction in all-cause mortality for participants receiving baricitinib compared to those receiving placebo at 28 days which was sustained at 60 days.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> </p><p>Then in May 2022, the FDA approved use of baricitinib for the treatment of adults hospitalized with COVID-19 who require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation with a recommended dose of 4 mg once daily for 14 days or until hospital discharge, whichever happens first.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span class="cite-bracket">&#91;</span>48<span class="cite-bracket">&#93;</span></a></sup> </p><p>In March 2022, the <a href="/wiki/RECOVERY_Trial" title="RECOVERY Trial">RECOVERY trial</a> reported that the use of baricitinib cut the risk of death by about a fifth in about 12,000 participants.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span class="cite-bracket">&#91;</span>49<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span class="cite-bracket">&#91;</span>51<span class="cite-bracket">&#93;</span></a></sup> </p> <div class="mw-heading mw-heading2"><h2 id="References">References</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=13" title="Edit section: References"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist"> <div class="mw-references-wrap mw-references-columns"><ol class="references"> <li id="cite_note-Olumiant_AU_PI-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Olumiant_AU_PI_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Olumiant_AU_PI_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2018-PI-01225-1">"Olumiant Product Information"</a> <span class="cs1-format">(PDF)</span>. <i><a href="/wiki/Therapeutic_Goods_Administration" title="Therapeutic Goods Administration">Therapeutic Goods Administration</a> (TGA)</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210920213103/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&amp;id=CP-2018-PI-01225-1">Archived</a> from the original on 20 September 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">12 June</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Therapeutic+Goods+Administration+%28TGA%29&amp;rft.atitle=Olumiant+Product+Information&amp;rft_id=https%3A%2F%2Fwww.ebs.tga.gov.au%2Febs%2Fpicmi%2Fpicmirepository.nsf%2Fpdf%3FOpenAgent%26id%3DCP-2018-PI-01225-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-Drugs.com_pregnancy-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Drugs.com_pregnancy_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Drugs.com_pregnancy_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/pregnancy/baricitinib.html">"Baricitinib (Olumiant) Use During Pregnancy"</a>. <i>Drugs.com</i>. 8 November 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200626063309/https://www.drugs.com/pregnancy/baricitinib.html">Archived</a> from the original on 26 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Baricitinib+%28Olumiant%29+Use+During+Pregnancy&amp;rft.date=2019-11-08&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fpregnancy%2Fbaricitinib.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA-AllBoxedWarnings-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA-AllBoxedWarnings_3-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802">"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)"</a>. <i>nctr-crs.fda.gov</i>. <a href="/wiki/FDA" class="mw-redirect" title="FDA">FDA</a><span class="reference-accessdate">. Retrieved <span class="nowrap">22 October</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=nctr-crs.fda.gov&amp;rft.atitle=FDA-sourced+list+of+all+drugs+with+black+box+warnings+%28Use+Download+Full+Results+and+View+Query+links.%29&amp;rft_id=https%3A%2F%2Fnctr-crs.fda.gov%2Ffdalabel%2Fui%2Fspl-summaries%2Fcriteria%2F343802&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.tga.gov.au/auspar/auspar-baricitinib-0">"AusPAR: Baricitinib"</a>. <i><a href="/wiki/Therapeutic_Goods_Administration" title="Therapeutic Goods Administration">Therapeutic Goods Administration</a> (TGA)</i>. 20 May 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210520045029/https://www.tga.gov.au/auspar/auspar-baricitinib-0">Archived</a> from the original on 20 May 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">11 June</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Therapeutic+Goods+Administration+%28TGA%29&amp;rft.atitle=AusPAR%3A+Baricitinib&amp;rft.date=2021-05-20&amp;rft_id=https%3A%2F%2Fwww.tga.gov.au%2Fauspar%2Fauspar-baricitinib-0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00410&amp;lang=en">"Summary Basis of Decision (SBD) for Olumiant"</a>. <i><a href="/wiki/Health_Canada" title="Health Canada">Health Canada</a></i>. 23 October 2014. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220531071908/https://hpr-rps.hres.ca/reg-content/summary-basis-decision-detailTwo.php?linkID=SBD00410&amp;lang=en">Archived</a> from the original on 31 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">29 May</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Health+Canada&amp;rft.atitle=Summary+Basis+of+Decision+%28SBD%29+for+Olumiant&amp;rft.date=2014-10-23&amp;rft_id=https%3A%2F%2Fhpr-rps.hres.ca%2Freg-content%2Fsummary-basis-decision-detailTwo.php%3FlinkID%3DSBD00410%26lang%3Den&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1710876504060">"Regulatory Decision Summary for Olumiant"</a>. <i>Drug and Health Products Portal</i>. 26 January 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drug+and+Health+Products+Portal&amp;rft.atitle=Regulatory+Decision+Summary+for+Olumiant&amp;rft.date=2024-01-26&amp;rft_id=https%3A%2F%2Fdhpp.hpfb-dgpsa.ca%2Freview-documents%2Fresource%2FRDS1710876504060&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-Olumiant_FDA_label-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Olumiant_FDA_label_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Olumiant_FDA_label_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Olumiant_FDA_label_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Olumiant_FDA_label_7-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=866e9f35-9035-4581-a4b1-75a621ab55cf">"Olumiant- baricitinib tablet, film coated"</a>. <i>DailyMed</i>. 13 November 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200927111424/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=866e9f35-9035-4581-a4b1-75a621ab55cf">Archived</a> from the original on 27 September 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DailyMed&amp;rft.atitle=Olumiant-+baricitinib+tablet%2C+film+coated&amp;rft.date=2019-11-13&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3D866e9f35-9035-4581-a4b1-75a621ab55cf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-Olumiant_EPAR-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Olumiant_EPAR_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Olumiant_EPAR_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Olumiant_EPAR_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Olumiant_EPAR_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Olumiant_EPAR_8-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ema.europa.eu/en/medicines/human/EPAR/olumiant">"Olumiant EPAR"</a>. <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA). 3 December 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210825064838/https://www.ema.europa.eu/en/medicines/human/EPAR/olumiant">Archived</a> from the original on 25 August 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">17 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Olumiant+EPAR&amp;rft.pub=European+Medicines+Agency+%28EMA%29&amp;rft.date=2019-12-03&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fmedicines%2Fhuman%2FEPAR%2Folumiant&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.</span> </li> <li id="cite_note-FDA_snapshot-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_snapshot_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_snapshot_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FDA_snapshot_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FDA_snapshot_9-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-olumiant">"Drug Trials Snapshots: Olumiant"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. 31 May 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191213230735/https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-olumiant">Archived</a> from the original on 13 December 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">16 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Drug+Trials+Snapshots%3A+Olumiant&amp;rft.date=2018-05-31&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fdrug-approvals-and-databases%2Fdrug-trials-snapshots-olumiant&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span> </li> <li id="cite_note-FDA_PR_20220613-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_PR_20220613_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220613_10-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-systemic-treatment-alopecia-areata">"FDA Approves First Systemic Treatment for Alopecia Areata"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 13 June 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220614051142/https://www.fda.gov/news-events/press-announcements/fda-approves-first-systemic-treatment-alopecia-areata">Archived</a> from the original on 14 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+First+Systemic+Treatment+for+Alopecia+Areata&amp;rft.date=2022-06-13&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-first-systemic-treatment-alopecia-areata&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span> </li> <li id="cite_note-CHMP-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-CHMP_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CHMP_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004085/WC500218183.pdf">"Summary of opinion for Olumiant"</a> <span class="cs1-format">(PDF)</span>. <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA). 15 December 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180315212105/http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004085/WC500218183.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 15 March 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">18 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Summary+of+opinion+for+Olumiant&amp;rft.pub=European+Medicines+Agency+%28EMA%29&amp;rft.date=2016-12-15&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FSummary_of_opinion_-_Initial_authorisation%2Fhuman%2F004085%2FWC500218183.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_approval-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_approval_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_approval_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FDA_approval_12-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/207924Orig1s000TOC.cfm">"Drug Approval Package: Olumiant (baricitinib)"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. 5 July 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200428001853/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/207924Orig1s000TOC.cfm">Archived</a> from the original on 28 April 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Drug+Approval+Package%3A+Olumiant+%28baricitinib%29&amp;rft.date=2018-07-05&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2018%2F207924Orig1s000TOC.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-EMA-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-EMA_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EMA_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EMA_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-EMA_13-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-EMA_13-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-EMA_13-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-EMA_13-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-EMA_13-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf">"Olumiant: EPAR – Product Information"</a> <span class="cs1-format">(PDF)</span>. <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a>. 13 February 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180712201644/http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 12 July 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">7 June</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Olumiant%3A+EPAR+%E2%80%93+Product+Information&amp;rft.pub=European+Medicines+Agency&amp;rft.date=2017-02-13&amp;rft_id=http%3A%2F%2Fwww.ema.europa.eu%2Fdocs%2Fen_GB%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F004085%2FWC500223723.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_FAQ-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_FAQ_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_FAQ_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/143825/download">"Frequently Asked Questions on Olumiant (Baricitinib) for the Treatment of COVID-19"</a> <span class="cs1-format">(PDF)</span>. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). 10 May 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210729004058/https://www.fda.gov/media/143825/download">Archived</a> from the original on 29 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Frequently+Asked+Questions+on+Olumiant+%28Baricitinib%29+for+the+Treatment+of+COVID-19&amp;rft.pub=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.date=2022-05-10&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F143825%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span> </li> <li id="cite_note-FDA_PR_20220510-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_PR_20220510_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_PR_20220510_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/fda-roundup-may-10-2022">"FDA Roundup: May 10, 2022"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 10 May 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220510213836/https://www.fda.gov/news-events/press-announcements/fda-roundup-may-10-2022">Archived</a> from the original on 10 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Roundup%3A+May+10%2C+2022&amp;rft.date=2022-05-10&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-roundup-may-10-2022&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-Lilly_PR_20220613-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lilly_PR_20220613_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lilly_PR_20220613_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.prnewswire.com/news-releases/fda-approves-lilly-and-incytes-olumiant-baricitinib-as-first-and-only-systemic-medicine-for-adults-with-severe-alopecia-areata-301567120.html">"FDA Approves Lilly and Incyte's Olumiant (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata"</a> (Press release). Eli Lilly. 13 June 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220614034511/https://www.prnewswire.com/news-releases/fda-approves-lilly-and-incytes-olumiant-baricitinib-as-first-and-only-systemic-medicine-for-adults-with-severe-alopecia-areata-301567120.html">Archived</a> from the original on 14 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 June</span> 2022</span> &#8211; via PR Newswire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Lilly+and+Incyte%27s+Olumiant+%28baricitinib%29+As+First+and+Only+Systemic+Medicine+for+Adults+with+Severe+Alopecia+Areata&amp;rft.pub=Eli+Lilly&amp;rft.date=2022-06-13&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Ffda-approves-lilly-and-incytes-olumiant-baricitinib-as-first-and-only-systemic-medicine-for-adults-with-severe-alopecia-areata-301567120.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831">"Xeljanz- tofacitinib tablet, film coated Xeljanz XR- tofacitinib tablet, film coated, extended release"</a>. <i>DailyMed</i>. 20 December 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201130235740/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831">Archived</a> from the original on 30 November 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">28 April</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DailyMed&amp;rft.atitle=Xeljanz-+tofacitinib+tablet%2C+film+coated+Xeljanz+XR-+tofacitinib+tablet%2C+film+coated%2C+extended+release&amp;rft.date=2019-12-20&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3Dcf74ba2f-afc5-4baa-8594-979c889a5831&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-November2012-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-November2012_18-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm327152.htm">"FDA approves Xeljanz for rheumatoid arthritis"</a> (Press release). 6 November 2012. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140402112113/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm327152.htm">Archived</a> from the original on 2 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">16 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+Xeljanz+for+rheumatoid+arthritis&amp;rft.date=2012-11-06&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm327152.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0f55a2a-4e0c-4cba-8571-03e1424486d7">"Inrebic- fedratinib hydrochloride capsule"</a>. <i>DailyMed</i>. 16 August 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210406064749/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0f55a2a-4e0c-4cba-8571-03e1424486d7">Archived</a> from the original on 6 April 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">28 April</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DailyMed&amp;rft.atitle=Inrebic-+fedratinib+hydrochloride+capsule&amp;rft.date=2019-08-16&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3Df0f55a2a-4e0c-4cba-8571-03e1424486d7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-Mesa2010-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mesa2010_20-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMesa2010" class="citation journal cs1">Mesa RA (June 2010). "Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis". <i>IDrugs</i>. <b>13</b> (6): 394–403. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20506062">20506062</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IDrugs&amp;rft.atitle=Ruxolitinib%2C+a+selective+JAK1+and+JAK2+inhibitor+for+the+treatment+of+myeloproliferative+neoplasms+and+psoriasis&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=394-403&amp;rft.date=2010-06&amp;rft_id=info%3Apmid%2F20506062&amp;rft.aulast=Mesa&amp;rft.aufirst=RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1c82580-87ae-11e0-bc84-0002a5d5c51b">"Jakafi- ruxolitinib tablet"</a>. <i>DailyMed</i>. 26 February 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201103114348/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1c82580-87ae-11e0-bc84-0002a5d5c51b">Archived</a> from the original on 3 November 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">28 April</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DailyMed&amp;rft.atitle=Jakafi-+ruxolitinib+tablet&amp;rft.date=2020-02-26&amp;rft_id=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3Df1c82580-87ae-11e0-bc84-0002a5d5c51b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://investor.lilly.com/news-releases/news-release-details/fda-approves-lilly-and-incytes-olumiantr-baricitinib-first-and">"FDA Approves Lilly and Incyte's Olumiant (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata"</a>. <i>Lilly Investors</i> (Press release). 13 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">23 February</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Lilly+and+Incyte%27s+Olumiant+%28baricitinib%29+As+First+and+Only+Systemic+Medicine+for+Adults+with+Severe+Alopecia+Areata&amp;rft.date=2022-06-13&amp;rft_id=https%3A%2F%2Finvestor.lilly.com%2Fnews-releases%2Fnews-release-details%2Ffda-approves-lilly-and-incytes-olumiantr-baricitinib-first-and&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-NDA-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-NDA_23-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugs.com/nda/baricitinib_160119.html">"Lilly and Incyte Announce Submission of NDA to FDA for Oral Once-Daily Baricitinib for Treatment of Moderate-to-Severe Rheumatoid Arthritis"</a>. <a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a>. 19 January 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210410200856/https://www.drugs.com/nda/baricitinib_160119.html">Archived</a> from the original on 10 April 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">18 December</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+and+Incyte+Announce+Submission+of+NDA+to+FDA+for+Oral+Once-Daily+Baricitinib+for+Treatment+of+Moderate-to-Severe+Rheumatoid+Arthritis&amp;rft.pub=Drugs.com&amp;rft.date=2016-01-19&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fnda%2Fbaricitinib_160119.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCarroll2017" class="citation news cs1">Carroll J (13 April 2017). <a rel="nofollow" class="external text" href="https://endpts.com/we-dont-know-when-exactly-lilly-will-announce-the-fdas-baricitinib-decision-but-watch-out-for-the-looming-pricing-squabble/">"We don't know when (exactly) Lilly will announce the FDA's baricitinib decision, but watch out for the looming pricing squabble"</a>. Endpoints News. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210125205605/https://endpts.com/we-dont-know-when-exactly-lilly-will-announce-the-fdas-baricitinib-decision-but-watch-out-for-the-looming-pricing-squabble/">Archived</a> from the original on 25 January 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">14 April</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=We+don%27t+know+when+%28exactly%29+Lilly+will+announce+the+FDA%27s+baricitinib+decision%2C+but+watch+out+for+the+looming+pricing+squabble&amp;rft.date=2017-04-13&amp;rft.aulast=Carroll&amp;rft.aufirst=J&amp;rft_id=https%3A%2F%2Fendpts.com%2Fwe-dont-know-when-exactly-lilly-will-announce-the-fdas-baricitinib-decision-but-watch-out-for-the-looming-pricing-squabble%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRamsey2017" class="citation news cs1">Ramsey L (17 April 2017). <a rel="nofollow" class="external text" href="http://www.businessinsider.com/fda-rejects-lilly-and-incytes-baricitinib-2017-4">"The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling"</a>. Business Insider. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190111232613/https://www.businessinsider.com/fda-rejects-lilly-and-incytes-baricitinib-2017-4">Archived</a> from the original on 11 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">14 April</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+FDA+shot+down+a+new+rheumatoid+arthritis+drug+%E2%80%94+and+the+companies+that+make+the+drug+are+tumbling&amp;rft.date=2017-04-17&amp;rft.aulast=Ramsey&amp;rft.aufirst=L&amp;rft_id=http%3A%2F%2Fwww.businessinsider.com%2Ffda-rejects-lilly-and-incytes-baricitinib-2017-4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFGrant2017" class="citation news cs1">Grant C (14 April 2017). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721">"Surprise FDA Rejection Will Sting This Biotech"</a></span>. <i>The Wall Street Journal</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190111175309/https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721">Archived</a> from the original on 11 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">14 April</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Surprise+FDA+Rejection+Will+Sting+This+Biotech&amp;rft.date=2017-04-14&amp;rft.aulast=Grant&amp;rft.aufirst=C&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fsurprise-fda-rejection-will-sting-this-biotech-1492185721&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.prnewswire.com/news-releases/lilly-receives-fda-breakthrough-therapy-designation-for-baricitinib-for-the-treatment-of-alopecia-areata-301024437.html">"Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata"</a> (Press release). Eli Lilly and Company. 16 March 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200317170907/https://www.prnewswire.com/news-releases/lilly-receives-fda-breakthrough-therapy-designation-for-baricitinib-for-the-treatment-of-alopecia-areata-301024437.html">Archived</a> from the original on 17 March 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">16 March</span> 2020</span> &#8211; via PR Newswire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Receives+FDA+Breakthrough+Therapy+Designation+for+Baricitinib+for+the+Treatment+of+Alopecia+Areata&amp;rft.pub=Eli+Lilly+and+Company&amp;rft.date=2020-03-16&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Flilly-receives-fda-breakthrough-therapy-designation-for-baricitinib-for-the-treatment-of-alopecia-areata-301024437.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clinicaltrials.gov/ct2/results?term=baricitinib&amp;Search=Search">"Baricitinib clinical trials"</a>. <i>ClinicalTrials.gov</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170204175409/https://clinicaltrials.gov/ct2/results?term=baricitinib&amp;Search=Search">Archived</a> from the original on 4 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Baricitinib+clinical+trials&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dbaricitinib%26Search%3DSearch&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://clinicaltrials.gov/ct2/results?term=baricitinib&amp;recr=&amp;type=&amp;rslt=&amp;age_v=&amp;gndr=&amp;cond=&amp;intr=&amp;titles=&amp;outc=&amp;spons=&amp;lead=&amp;id=&amp;state1=&amp;cntry1=&amp;state2=&amp;cntry2=&amp;state3=&amp;cntry3=&amp;locn=&amp;phase=2&amp;rcv_s=&amp;rcv_e=&amp;lup_s=&amp;lup_e=">"Baricitinib phase 3 clinical trials"</a>. <i>ClinicalTrials.gov</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170204161959/https://clinicaltrials.gov/ct2/results?term=baricitinib&amp;recr=&amp;type=&amp;rslt=&amp;age_v=&amp;gndr=&amp;cond=&amp;intr=&amp;titles=&amp;outc=&amp;spons=&amp;lead=&amp;id=&amp;state1=&amp;cntry1=&amp;state2=&amp;cntry2=&amp;state3=&amp;cntry3=&amp;locn=&amp;phase=2&amp;rcv_s=&amp;rcv_e=&amp;lup_s=&amp;lup_e=">Archived</a> from the original on 4 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=ClinicalTrials.gov&amp;rft.atitle=Baricitinib+phase+3+clinical+trials&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fresults%3Fterm%3Dbaricitinib%26recr%3D%26type%3D%26rslt%3D%26age_v%3D%26gndr%3D%26cond%3D%26intr%3D%26titles%3D%26outc%3D%26spons%3D%26lead%3D%26id%3D%26state1%3D%26cntry1%3D%26state2%3D%26cntry2%3D%26state3%3D%26cntry3%3D%26locn%3D%26phase%3D2%26rcv_s%3D%26rcv_e%3D%26lup_s%3D%26lup_e%3D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.technology.org/2022/03/29/treat-hair-alopecia-areata-success/">"Re-growing hair: New trials for alopecia areata treatment are a success - Technology Org"</a>. 29 March 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220331080347/https://www.technology.org/2022/03/29/treat-hair-alopecia-areata-success/">Archived</a> from the original on 31 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">30 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Re-growing+hair%3A+New+trials+for+alopecia+areata+treatment+are+a+success+-+Technology+Org&amp;rft.date=2022-03-29&amp;rft_id=https%3A%2F%2Fwww.technology.org%2F2022%2F03%2F29%2Ftreat-hair-alopecia-areata-success%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.clinicaltrialsarena.com/news/eli-lilly-to-study-baricitinib-for-covid-19-treatment/">"Eli Lilly to study baricitinib for Covid-19 treatment"</a>. <i>Clinical Trials Arena</i>. 13 April 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210817134014/https://www.clinicaltrialsarena.com/news/eli-lilly-to-study-baricitinib-for-covid-19-treatment/">Archived</a> from the original on 17 August 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">15 May</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Clinical+Trials+Arena&amp;rft.atitle=Eli+Lilly+to+study+baricitinib+for+Covid-19+treatment&amp;rft.date=2020-04-13&amp;rft_id=https%3A%2F%2Fwww.clinicaltrialsarena.com%2Fnews%2Feli-lilly-to-study-baricitinib-for-covid-19-treatment%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSaber-AyadHammoudehAbu-GharbiehHamoudi2021" class="citation journal cs1">Saber-Ayad M, Hammoudeh S, Abu-Gharbieh E, Hamoudi R, Tarazi H, Al-Tel TH, et&#160;al. (July 2021). <a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fph14070680">"Current Status of Baricitinib as a Repurposed Therapy for COVID-19"</a>. <i>Pharmaceuticals (Basel, Switzerland)</i>. <b>14</b> (7): 680. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fph14070680">10.3390/ph14070680</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308612">8308612</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34358107">34358107</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&amp;rft.atitle=Current+Status+of+Baricitinib+as+a+Repurposed+Therapy+for+COVID-19&amp;rft.volume=14&amp;rft.issue=7&amp;rft.pages=680&amp;rft.date=2021-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8308612%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34358107&amp;rft_id=info%3Adoi%2F10.3390%2Fph14070680&amp;rft.aulast=Saber-Ayad&amp;rft.aufirst=M&amp;rft.au=Hammoudeh%2C+S&amp;rft.au=Abu-Gharbieh%2C+E&amp;rft.au=Hamoudi%2C+R&amp;rft.au=Tarazi%2C+H&amp;rft.au=Al-Tel%2C+TH&amp;rft.au=Hamid%2C+Q&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.3390%252Fph14070680&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCantiniNiccoliMatarreseNicastri2021" class="citation journal cs1">Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D (August 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177073">"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact"</a>. <i>J Infect</i>. <b>81</b> (2): 318–356. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jinf.2020.04.017">10.1016/j.jinf.2020.04.017</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177073">7177073</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32333918">32333918</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Infect&amp;rft.atitle=Baricitinib+therapy+in+COVID-19%3A+A+pilot+study+on+safety+and+clinical+impact&amp;rft.volume=81&amp;rft.issue=2&amp;rft.pages=318-356&amp;rft.date=2021-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7177073%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32333918&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jinf.2020.04.017&amp;rft.aulast=Cantini&amp;rft.aufirst=F&amp;rft.au=Niccoli%2C+L&amp;rft.au=Matarrese%2C+D&amp;rft.au=Nicastri%2C+E&amp;rft.au=Stobbione%2C+P&amp;rft.au=Goletti%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7177073&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFTitanjiFarleyMehtaConnor-Schuler2021" class="citation journal cs1">Titanji BK, Farley MM, Mehta A, Connor-Schuler R, Moanna A, Cribbs SK, et&#160;al. (8 April 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337637">"Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019"</a>. <i>Clin Infect Dis</i>. <b>72</b> (7): 1247–1250. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fcid%2Fciaa879">10.1093/cid/ciaa879</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337637">7337637</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32597466">32597466</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Infect+Dis&amp;rft.atitle=Use+of+Baricitinib+in+Patients+With+Moderate+to+Severe+Coronavirus+Disease+2019&amp;rft.volume=72&amp;rft.issue=7&amp;rft.pages=1247-1250&amp;rft.date=2021-04-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7337637%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32597466&amp;rft_id=info%3Adoi%2F10.1093%2Fcid%2Fciaa879&amp;rft.aulast=Titanji&amp;rft.aufirst=BK&amp;rft.au=Farley%2C+MM&amp;rft.au=Mehta%2C+A&amp;rft.au=Connor-Schuler%2C+R&amp;rft.au=Moanna%2C+A&amp;rft.au=Cribbs%2C+SK&amp;rft.au=O%27Shea%2C+J&amp;rft.au=DeSilva%2C+K&amp;rft.au=Chan%2C+B&amp;rft.au=Edwards%2C+A&amp;rft.au=Gavegnano%2C+C&amp;rft.au=Schinazi%2C+RF&amp;rft.au=Marconi%2C+VC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7337637&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> </span> </li> <li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStebbingSánchez_NievasFalconeYouhanna2021" class="citation journal cs1">Stebbing J, Sánchez Nievas G, Falcone M, Youhanna S, Richardson P, Ottaviani S, et&#160;al. (January 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775747">"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality"</a>. <i>Science Advances</i>. <b>7</b> (1): eabe4724. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2021SciA....7.4724S">2021SciA....7.4724S</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fsciadv.abe4724">10.1126/sciadv.abe4724</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775747">7775747</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33187978">33187978</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science+Advances&amp;rft.atitle=JAK+inhibition+reduces+SARS-CoV-2+liver+infectivity+and+modulates+inflammatory+responses+to+reduce+morbidity+and+mortality&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=eabe4724&amp;rft.date=2021-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7775747%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33187978&amp;rft_id=info%3Adoi%2F10.1126%2Fsciadv.abe4724&amp;rft_id=info%3Abibcode%2F2021SciA....7.4724S&amp;rft.aulast=Stebbing&amp;rft.aufirst=J&amp;rft.au=S%C3%A1nchez+Nievas%2C+G&amp;rft.au=Falcone%2C+M&amp;rft.au=Youhanna%2C+S&amp;rft.au=Richardson%2C+P&amp;rft.au=Ottaviani%2C+S&amp;rft.au=Shen%2C+JX&amp;rft.au=Sommerauer%2C+C&amp;rft.au=Tiseo%2C+G&amp;rft.au=Ghiadoni%2C+L&amp;rft.au=Virdis%2C+A&amp;rft.au=Monzani%2C+F&amp;rft.au=Rizos%2C+LR&amp;rft.au=Forfori%2C+F&amp;rft.au=Avenda%C3%B1o+C%C3%A9spedes%2C+A&amp;rft.au=De+Marco%2C+S&amp;rft.au=Carrozzi%2C+L&amp;rft.au=Lena%2C+F&amp;rft.au=S%C3%A1nchez-Jurado%2C+PM&amp;rft.au=Lacerenza%2C+LG&amp;rft.au=Cesira%2C+N&amp;rft.au=Caldevilla+Bernardo%2C+D&amp;rft.au=Perrella%2C+A&amp;rft.au=Niccoli%2C+L&amp;rft.au=M%C3%A9ndez%2C+LS&amp;rft.au=Matarrese%2C+D&amp;rft.au=Goletti%2C+D&amp;rft.au=Tan%2C+YJ&amp;rft.au=Monteil%2C+V&amp;rft.au=Dranitsaris%2C+G&amp;rft.au=Cantini%2C+F&amp;rft.au=Farcomeni%2C+A&amp;rft.au=Dutta%2C+S&amp;rft.au=Burley%2C+SK&amp;rft.au=Zhang%2C+H&amp;rft.au=Pistello%2C+M&amp;rft.au=Li%2C+W&amp;rft.au=Romero%2C+MM&amp;rft.au=Andr%C3%A9s+Pretel%2C+F&amp;rft.au=Sim%C3%B3n-Talero%2C+RS&amp;rft.au=Garc%C3%ADa-Molina%2C+R&amp;rft.au=Kutter%2C+C&amp;rft.au=Felce%2C+JH&amp;rft.au=Nizami%2C+ZF&amp;rft.au=Miklosi%2C+AG&amp;rft.au=Penninger%2C+JM&amp;rft.au=Menichetti%2C+F&amp;rft.au=Mirazimi%2C+A&amp;rft.au=Abizanda%2C+P&amp;rft.au=Lauschke%2C+VM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7775747&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKalilPattersonMehtaTomashek2021" class="citation journal cs1">Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et&#160;al. (4 March 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745180">"Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19"</a>. <i>N Engl J Med</i>. <b>384</b> (9): 795–807. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa2031994">10.1056/NEJMoa2031994</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745180">7745180</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33306283">33306283</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N+Engl+J+Med&amp;rft.atitle=Baricitinib+plus+Remdesivir+for+Hospitalized+Adults+with+Covid-19&amp;rft.volume=384&amp;rft.issue=9&amp;rft.pages=795-807&amp;rft.date=2021-03-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7745180%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33306283&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2031994&amp;rft.aulast=Kalil&amp;rft.aufirst=AC&amp;rft.au=Patterson%2C+TF&amp;rft.au=Mehta%2C+AK&amp;rft.au=Tomashek%2C+KM&amp;rft.au=Wolfe%2C+CR&amp;rft.au=Ghazaryan%2C+V&amp;rft.au=Marconi%2C+VC&amp;rft.au=Ruiz-Palacios%2C+GM&amp;rft.au=Hsieh%2C+L&amp;rft.au=Kline%2C+S&amp;rft.au=Tapson%2C+V&amp;rft.au=Iovine%2C+NM&amp;rft.au=Jain%2C+MK&amp;rft.au=Sweeney%2C+DA&amp;rft.au=El+Sahly%2C+HM&amp;rft.au=Branche%2C+AR&amp;rft.au=Regalado+Pineda%2C+J&amp;rft.au=Lye%2C+DC&amp;rft.au=Sandkovsky%2C+U&amp;rft.au=Luetkemeyer%2C+AF&amp;rft.au=Cohen%2C+SH&amp;rft.au=Finberg%2C+RW&amp;rft.au=Jackson%2C+PE&amp;rft.au=Taiwo%2C+B&amp;rft.au=Paules%2C+CI&amp;rft.au=Arguinchona%2C+H&amp;rft.au=Erdmann%2C+N&amp;rft.au=Ahuja%2C+N&amp;rft.au=Frank%2C+M&amp;rft.au=Oh%2C+MD&amp;rft.au=Kim%2C+ES&amp;rft.au=Tan%2C+SY&amp;rft.au=Mularski%2C+RA&amp;rft.au=Nielsen%2C+H&amp;rft.au=Ponce%2C+PO&amp;rft.au=Taylor%2C+BS&amp;rft.au=Larson%2C+L&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Saklawi%2C+Y&amp;rft.au=Cantos%2C+VD&amp;rft.au=Ko%2C+ER&amp;rft.au=Engemann%2C+JJ&amp;rft.au=Amin%2C+AN&amp;rft.au=Watanabe%2C+M&amp;rft.au=Billings%2C+J&amp;rft.au=Elie%2C+MC&amp;rft.au=Davey%2C+RT&amp;rft.au=Burgess%2C+TH&amp;rft.au=Ferreira%2C+J&amp;rft.au=Green%2C+M&amp;rft.au=Makowski%2C+M&amp;rft.au=Cardoso%2C+A&amp;rft.au=de+Bono%2C+S&amp;rft.au=Bonnett%2C+T&amp;rft.au=Proschan%2C+M&amp;rft.au=Deye%2C+GA&amp;rft.au=Dempsey%2C+W&amp;rft.au=Nayak%2C+SU&amp;rft.au=Dodd%2C+LE&amp;rft.au=Beigel%2C+JH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7745180&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_PR_20201119-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_PR_20201119_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-FDA_PR_20201119_37-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19">"Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 19 November 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201119213826/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19">Archived</a> from the original on 19 November 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">19 November</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+%28COVID-19%29+Update%3A+FDA+Authorizes+Drug+Combination+for+Treatment+of+COVID-19&amp;rft.date=2020-11-19&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fcoronavirus-covid-19-update-fda-authorizes-drug-combination-treatment-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span> </li> <li id="cite_note-FDA_CDER_Review-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_CDER_Review_38-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/144473/download">"Baricitinib Emergency Use Authorization (EUA) Center for Drug Evaluation and Research (CDER) Review"</a> <span class="cs1-format">(PDF)</span>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. November 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210310025144/https://www.fda.gov/media/144473/download">Archived</a> from the original on 10 March 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Baricitinib+Emergency+Use+Authorization+%28EUA%29+Center+for+Drug+Evaluation+and+Research+%28CDER%29+Review&amp;rft.date=2020-11&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F144473%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-WHO_guidelines-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHO_guidelines_39-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFWorld_Health_Organization2021" class="citation report cs1"><a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (2021). Therapeutics and COVID-19: living guideline, 6 July 2021 (Report). <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO). <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10665%2F342368">10665/342368</a></span>. WHO/2019-nCoV/therapeutics/2021.2.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=Therapeutics+and+COVID-19%3A+living+guideline%2C+6+July+2021&amp;rft.pub=World+Health+Organization+%28WHO%29&amp;rft.date=2021&amp;rft_id=info%3Ahdl%2F10665%2F342368&amp;rft.au=World+Health+Organization&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-who-lg-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-who-lg_40-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFRochwergAgarwalSiemieniukAgoritsas2020" class="citation journal cs1">Rochwerg B, Agarwal A, Siemieniuk RA, Agoritsas T, Lamontagne F, Askie L, et&#160;al. (September 2020). <a rel="nofollow" class="external text" href="https://www.theguardian.com/world/2020/nov/20/remdesivir-dont-use-drug-trump-took-for-covid-19-who-says">"A living WHO guideline on drugs for covid-19"</a>. <i>BMJ</i>. <b>370</b>: m3379. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.m3379">10.1136/bmj.m3379</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32887691">32887691</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=A+living+WHO+guideline+on+drugs+for+covid-19&amp;rft.volume=370&amp;rft.pages=m3379&amp;rft.date=2020-09&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.m3379&amp;rft_id=info%3Apmid%2F32887691&amp;rft.aulast=Rochwerg&amp;rft.aufirst=B&amp;rft.au=Agarwal%2C+A&amp;rft.au=Siemieniuk%2C+RA&amp;rft.au=Agoritsas%2C+T&amp;rft.au=Lamontagne%2C+F&amp;rft.au=Askie%2C+L&amp;rft.au=Lytvyn%2C+L&amp;rft.au=Leo%2C+YS&amp;rft.au=Macdonald%2C+H&amp;rft.au=Zeng%2C+L&amp;rft.au=Amin%2C+W&amp;rft.au=Burhan%2C+E&amp;rft.au=Bausch%2C+FJ&amp;rft.au=Calfee%2C+CS&amp;rft.au=Cecconi%2C+M&amp;rft.au=Chanda%2C+D&amp;rft.au=Du%2C+B&amp;rft.au=Geduld%2C+H&amp;rft.au=Gee%2C+P&amp;rft.au=Harley%2C+N&amp;rft.au=Hashimi%2C+M&amp;rft.au=Hunt%2C+B&amp;rft.au=Kabra%2C+SK&amp;rft.au=Kanda%2C+S&amp;rft.au=Kawano-Dourado%2C+L&amp;rft.au=Kim%2C+YJ&amp;rft.au=Kissoon%2C+N&amp;rft.au=Kwizera%2C+A&amp;rft.au=Mahaka%2C+I&amp;rft.au=Manai%2C+H&amp;rft.au=Mino%2C+G&amp;rft.au=Nsutebu%2C+E&amp;rft.au=Preller%2C+J&amp;rft.au=Pshenichnaya%2C+N&amp;rft.au=Qadir%2C+N&amp;rft.au=Sabzwari%2C+S&amp;rft.au=Sarin%2C+R&amp;rft.au=Shankar-Hari%2C+M&amp;rft.au=Sharland%2C+M&amp;rft.au=Shen%2C+Y&amp;rft.au=Ranganathan%2C+SS&amp;rft.au=Souza%2C+JP&amp;rft.au=Stegemann%2C+M&amp;rft.au=De+Sutter%2C+A&amp;rft.au=Ugarte%2C+S&amp;rft.au=Venkatapuram%2C+S&amp;rft.au=Dat%2C+VQ&amp;rft.au=Vuyiseka%2C+D&amp;rft.au=Wijewickrama%2C+A&amp;rft.au=Maguire%2C+B&amp;rft.au=Zeraatkar%2C+D&amp;rft.au=Bartoszko%2C+JJ&amp;rft.au=Ge%2C+L&amp;rft.au=Brignardello-Petersen%2C+R&amp;rft.au=Owen%2C+A&amp;rft.au=Guyatt%2C+G&amp;rft.au=Diaz%2C+J&amp;rft.au=Jacobs%2C+M&amp;rft.au=Vandvik%2C+PO&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fworld%2F2020%2Fnov%2F20%2Fremdesivir-dont-use-drug-trump-took-for-covid-19-who-says&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_EUA-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_EUA_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_EUA_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/143822/download">"Baricitinib Emergency Use Authorization (EUA)"</a> <span class="cs1-format">(PDF)</span>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. July 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210912074636/https://www.fda.gov/media/143822/download">Archived</a> from the original on 12 September 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Baricitinib+Emergency+Use+Authorization+%28EUA%29&amp;rft.date=2021-07&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F143822%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_EUA_Fact_Sheet-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_EUA_Fact_Sheet_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_EUA_Fact_Sheet_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/media/143825/download">"Fact Sheet for Baricitinib Emergency Use Authorization (EUA)"</a> <span class="cs1-format">(PDF)</span>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i>. July 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210729004058/https://www.fda.gov/media/143825/download">Archived</a> from the original on 29 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">31 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=U.S.+Food+and+Drug+Administration+%28FDA%29&amp;rft.atitle=Fact+Sheet+for+Baricitinib+Emergency+Use+Authorization+%28EUA%29&amp;rft.date=2021-07&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F143825%2Fdownload&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFMarconiRamanande_BonoKartman2021" class="citation journal cs1">Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, et&#160;al. (December 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409066">"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial"</a>. <i>Lancet Respir Med</i>. <b>9</b> (12): 1407–1418. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS2213-2600%2821%2900331-3">10.1016/S2213-2600(21)00331-3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409066">8409066</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34480861">34480861</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Respir+Med&amp;rft.atitle=Efficacy+and+safety+of+baricitinib+for+the+treatment+of+hospitalised+adults+with+COVID-19+%28COV-BARRIER%29%3A+a+randomised%2C+double-blind%2C+parallel-group%2C+placebo-controlled+phase+3+trial&amp;rft.volume=9&amp;rft.issue=12&amp;rft.pages=1407-1418&amp;rft.date=2021-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409066%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34480861&amp;rft_id=info%3Adoi%2F10.1016%2FS2213-2600%2821%2900331-3&amp;rft.aulast=Marconi&amp;rft.aufirst=VC&amp;rft.au=Ramanan%2C+AV&amp;rft.au=de+Bono%2C+S&amp;rft.au=Kartman%2C+CE&amp;rft.au=Krishnan%2C+V&amp;rft.au=Liao%2C+R&amp;rft.au=Piruzeli%2C+ML&amp;rft.au=Goldman%2C+JD&amp;rft.au=Alatorre+Alexander%2C+J&amp;rft.au=de+Cassia+Pellegrini%2C+R&amp;rft.au=Estrada%2C+V&amp;rft.au=Som%2C+M&amp;rft.au=Cardoso%2C+A&amp;rft.au=Chakladar%2C+S&amp;rft.au=Crowe%2C+B&amp;rft.au=Reis%2C+P&amp;rft.au=Zhang%2C+X&amp;rft.au=Adams%2C+DH&amp;rft.au=Ely%2C+EW&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409066&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-olumiant-hospitalised-covid-19-patients-requiring-supplemental-oxygen">"EMA starts evaluating use of Olumiant in hospitalized COVID-19 patients requiring supplemental oxygen"</a>. <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA). 29 April 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220614051141/https://www.ema.europa.eu/en/news/ema-starts-evaluating-use-olumiant-hospitalised-covid-19-patients-requiring-supplemental-oxygen">Archived</a> from the original on 14 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">25 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=EMA+starts+evaluating+use+of+Olumiant+in+hospitalized+COVID-19+patients+requiring+supplemental+oxygen&amp;rft.pub=European+Medicines+Agency+%28EMA%29&amp;rft.date=2021-04-29&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-starts-evaluating-use-olumiant-hospitalised-covid-19-patients-requiring-supplemental-oxygen&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-FDA_PR_20210730-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA_PR_20210730_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA_PR_20210730_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-30-2021">"Coronavirus (COVID-19) Update: July 30, 2021"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 30 July 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210730215454/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-july-30-2021">Archived</a> from the original on 30 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">30 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+%28COVID-19%29+Update%3A+July+30%2C+2021&amp;rft.date=2021-07-30&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fcoronavirus-covid-19-update-july-30-2021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/12px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/18px-PD-icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/24px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span> </li> <li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.who.int/news/item/14-01-2022-who-recommends-two-new-drugs-to-treat-covid-19">"WHO recommends two new drugs to treat COVID-19"</a> (Press release).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=WHO+recommends+two+new+drugs+to+treat+COVID-19&amp;rft_id=https%3A%2F%2Fwww.who.int%2Fnews%2Fitem%2F14-01-2022-who-recommends-two-new-drugs-to-treat-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFElyRamananKartmande_Bono2022" class="citation journal cs1">Ely EW, Ramanan AV, Kartman CE, de Bono S, Liao R, Piruzeli ML, et&#160;al. (April 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813065">"Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial"</a>. <i>Lancet Respir Med</i>. <b>10</b> (4): 327–336. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS2213-2600%2822%2900006-6">10.1016/S2213-2600(22)00006-6</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813065">8813065</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35123660">35123660</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Respir+Med&amp;rft.atitle=Efficacy+and+safety+of+baricitinib+plus+standard+of+care+for+the+treatment+of+critically+ill+hospitalised+adults+with+COVID-19+on+invasive+mechanical+ventilation+or+extracorporeal+membrane+oxygenation%3A+an+exploratory%2C+randomised%2C+placebo-controlled+trial&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=327-336&amp;rft.date=2022-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8813065%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F35123660&amp;rft_id=info%3Adoi%2F10.1016%2FS2213-2600%2822%2900006-6&amp;rft.aulast=Ely&amp;rft.aufirst=EW&amp;rft.au=Ramanan%2C+AV&amp;rft.au=Kartman%2C+CE&amp;rft.au=de+Bono%2C+S&amp;rft.au=Liao%2C+R&amp;rft.au=Piruzeli%2C+ML&amp;rft.au=Goldman%2C+JD&amp;rft.au=Saraiva%2C+JF&amp;rft.au=Chakladar%2C+S&amp;rft.au=Marconi%2C+VC&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8813065&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> </span> </li> <li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.pharmacytimes.com/view/fda-approves-baricitinib-for-certain-adult-patients-hospitalized-with-covid-19">"FDA Approves Baricitinib for Certain Adult Patients Hospitalized With COVID-19"</a> (Press release).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+Approves+Baricitinib+for+Certain+Adult+Patients+Hospitalized+With+COVID-19&amp;rft_id=https%3A%2F%2Fwww.pharmacytimes.com%2Fview%2Ffda-approves-baricitinib-for-certain-adult-patients-hospitalized-with-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span> </span> </li> <li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.recoverytrial.net/news/baricitinib">"New RECOVERY trial result: baricitinib reduces deaths in patients hospitalised with COVID-19 — RECOVERY Trial"</a>. <i>www.recoverytrial.net</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220304093003/https://www.recoverytrial.net/news/baricitinib">Archived</a> from the original on 4 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.recoverytrial.net&amp;rft.atitle=New+RECOVERY+trial+result%3A+baricitinib+reduces+deaths+in+patients+hospitalised+with+COVID-19+%E2%80%94+RECOVERY+Trial&amp;rft_id=https%3A%2F%2Fwww.recoverytrial.net%2Fnews%2Fbaricitinib&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.bbc.com/news/health-60601750">"Another life-saving Covid drug identified"</a>. <i>BBC News</i>. 3 March 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220305002342/https://www.bbc.com/news/health-60601750">Archived</a> from the original on 5 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Another+life-saving+Covid+drug+identified&amp;rft.date=2022-03-03&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-60601750&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> <li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFAbaniAbbasAbbasAbbas2022" class="citation journal cs1">Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et&#160;al. (RECOVERY Collaborative Group) (July 2022). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333998">"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis"</a>. <i>Lancet</i>. <b>400</b> (10349): 359–368. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2822%2901109-6">10.1016/S0140-6736(22)01109-6</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333998">9333998</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35908569">35908569</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:247216504">247216504</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Baricitinib+in+patients+admitted+to+hospital+with+COVID-19+%28RECOVERY%29%3A+a+randomised%2C+controlled%2C+open-label%2C+platform+trial+and+updated+meta-analysis&amp;rft.volume=400&amp;rft.issue=10349&amp;rft.pages=359-368&amp;rft.date=2022-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9333998%23id-name%3DPMC&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A247216504%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35908569&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2822%2901109-6&amp;rft.aulast=Abani&amp;rft.aufirst=O&amp;rft.au=Abbas%2C+A&amp;rft.au=Abbas%2C+F&amp;rft.au=Abbas%2C+J&amp;rft.au=Abbas%2C+K&amp;rft.au=Abbas%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9333998&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></span> </li> </ol></div></div> <div class="mw-heading mw-heading2"><h2 id="Further_reading">Further reading</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Baricitinib&amp;action=edit&amp;section=14" title="Edit section: Further reading"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div> <style data-mw-deduplicate="TemplateStyles:r1239549316">.mw-parser-output .refbegin{margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li{margin-left:0;padding-left:3.2em;text-indent:-3.2em}.mw-parser-output .refbegin-hanging-indents ul,.mw-parser-output .refbegin-hanging-indents ul li{list-style:none}@media(max-width:720px){.mw-parser-output .refbegin-hanging-indents>ul>li{padding-left:1.6em;text-indent:-1.6em}}.mw-parser-output .refbegin-columns{margin-top:0.3em}.mw-parser-output .refbegin-columns ul{margin-top:0}.mw-parser-output .refbegin-columns li{page-break-inside:avoid;break-inside:avoid-column}@media screen{.mw-parser-output .refbegin{font-size:90%}}</style><div class="refbegin" style=""> <ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFCingolaniTummoloMontemurroGremese2020" class="citation journal cs1">Cingolani A, Tummolo AM, Montemurro G, Gremese E, Larosa L, Cipriani MC, et&#160;al. (October 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855">"Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab"</a>. <i>Infection</i>. <b>48</b> (5): 767–771. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs15010-020-01476-7">10.1007/s15010-020-01476-7</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340855">7340855</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32642806">32642806</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection&amp;rft.atitle=Baricitinib+as+rescue+therapy+in+a+patient+with+COVID-19+with+no+complete+response+to+sarilumab&amp;rft.volume=48&amp;rft.issue=5&amp;rft.pages=767-771&amp;rft.date=2020-10&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7340855%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32642806&amp;rft_id=info%3Adoi%2F10.1007%2Fs15010-020-01476-7&amp;rft.aulast=Cingolani&amp;rft.aufirst=A&amp;rft.au=Tummolo%2C+AM&amp;rft.au=Montemurro%2C+G&amp;rft.au=Gremese%2C+E&amp;rft.au=Larosa%2C+L&amp;rft.au=Cipriani%2C+MC&amp;rft.au=Pasciuto%2C+G&amp;rft.au=Liperoti%2C+R&amp;rft.au=Murri%2C+R&amp;rft.au=Pirronti%2C+T&amp;rft.au=Cauda%2C+R&amp;rft.au=Fantoni%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7340855&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFJorgensenTseBurryDresser2020" class="citation journal cs1">Jorgensen SC, Tse CL, Burry L, Dresser LD (August 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323235">"Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID-19"</a>. <i>Pharmacotherapy</i>. <b>40</b> (8): 843–856. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fphar.2438">10.1002/phar.2438</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323235">7323235</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32542785">32542785</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacotherapy&amp;rft.atitle=Baricitinib%3A+A+Review+of+Pharmacology%2C+Safety%2C+and+Emerging+Clinical+Experience+in+COVID-19&amp;rft.volume=40&amp;rft.issue=8&amp;rft.pages=843-856&amp;rft.date=2020-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7323235%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32542785&amp;rft_id=info%3Adoi%2F10.1002%2Fphar.2438&amp;rft.aulast=Jorgensen&amp;rft.aufirst=SC&amp;rft.au=Tse%2C+CL&amp;rft.au=Burry%2C+L&amp;rft.au=Dresser%2C+LD&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7323235&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFKalilPattersonMehtaTomashek2021" class="citation journal cs1">Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et&#160;al. (March 2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745180">"Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19"</a>. <i>The New England Journal of Medicine</i>. <b>384</b> (9): 795–807. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa2031994">10.1056/NEJMoa2031994</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745180">7745180</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33306283">33306283</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Baricitinib+plus+Remdesivir+for+Hospitalized+Adults+with+Covid-19&amp;rft.volume=384&amp;rft.issue=9&amp;rft.pages=795-807&amp;rft.date=2021-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7745180%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33306283&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa2031994&amp;rft.aulast=Kalil&amp;rft.aufirst=AC&amp;rft.au=Patterson%2C+TF&amp;rft.au=Mehta%2C+AK&amp;rft.au=Tomashek%2C+KM&amp;rft.au=Wolfe%2C+CR&amp;rft.au=Ghazaryan%2C+V&amp;rft.au=Marconi%2C+VC&amp;rft.au=Ruiz-Palacios%2C+GM&amp;rft.au=Hsieh%2C+L&amp;rft.au=Kline%2C+S&amp;rft.au=Tapson%2C+V&amp;rft.au=Iovine%2C+NM&amp;rft.au=Jain%2C+MK&amp;rft.au=Sweeney%2C+DA&amp;rft.au=El+Sahly%2C+HM&amp;rft.au=Branche%2C+AR&amp;rft.au=Regalado+Pineda%2C+J&amp;rft.au=Lye%2C+DC&amp;rft.au=Sandkovsky%2C+U&amp;rft.au=Luetkemeyer%2C+AF&amp;rft.au=Cohen%2C+SH&amp;rft.au=Finberg%2C+RW&amp;rft.au=Jackson%2C+PE&amp;rft.au=Taiwo%2C+B&amp;rft.au=Paules%2C+CI&amp;rft.au=Arguinchona%2C+H&amp;rft.au=Erdmann%2C+N&amp;rft.au=Ahuja%2C+N&amp;rft.au=Frank%2C+M&amp;rft.au=Oh%2C+MD&amp;rft.au=Kim%2C+ES&amp;rft.au=Tan%2C+SY&amp;rft.au=Mularski%2C+RA&amp;rft.au=Nielsen%2C+H&amp;rft.au=Ponce%2C+PO&amp;rft.au=Taylor%2C+BS&amp;rft.au=Larson%2C+L&amp;rft.au=Rouphael%2C+NG&amp;rft.au=Saklawi%2C+Y&amp;rft.au=Cantos%2C+VD&amp;rft.au=Ko%2C+ER&amp;rft.au=Engemann%2C+JJ&amp;rft.au=Amin%2C+AN&amp;rft.au=Watanabe%2C+M&amp;rft.au=Billings%2C+J&amp;rft.au=Elie%2C+MC&amp;rft.au=Davey%2C+RT&amp;rft.au=Burgess%2C+TH&amp;rft.au=Ferreira%2C+J&amp;rft.au=Green%2C+M&amp;rft.au=Makowski%2C+M&amp;rft.au=Cardoso%2C+A&amp;rft.au=de+Bono%2C+S&amp;rft.au=Bonnett%2C+T&amp;rft.au=Proschan%2C+M&amp;rft.au=Deye%2C+GA&amp;rft.au=Dempsey%2C+W&amp;rft.au=Nayak%2C+SU&amp;rft.au=Dodd%2C+LE&amp;rft.au=Beigel%2C+JH&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7745180&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFSeifAazamiKhoshmirsafaKamali2020" class="citation journal cs1">Seif F, Aazami H, Khoshmirsafa M, Kamali M, Mohsenzadegan M, Pornour M, et&#160;al. (2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270061">"JAK Inhibition as a New Treatment Strategy for Patients with COVID-19"</a>. <i>International Archives of Allergy and Immunology</i>. <b>181</b> (6): 467–475. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000508247">10.1159/000508247</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270061">7270061</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32392562">32392562</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Archives+of+Allergy+and+Immunology&amp;rft.atitle=JAK+Inhibition+as+a+New+Treatment+Strategy+for+Patients+with+COVID-19&amp;rft.volume=181&amp;rft.issue=6&amp;rft.pages=467-475&amp;rft.date=2020&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7270061%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32392562&amp;rft_id=info%3Adoi%2F10.1159%2F000508247&amp;rft.aulast=Seif&amp;rft.aufirst=F&amp;rft.au=Aazami%2C+H&amp;rft.au=Khoshmirsafa%2C+M&amp;rft.au=Kamali%2C+M&amp;rft.au=Mohsenzadegan%2C+M&amp;rft.au=Pornour%2C+M&amp;rft.au=Mansouri%2C+D&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7270061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFStebbingKrishnande_BonoOttaviani2020" class="citation journal cs1">Stebbing J, Krishnan V, de Bono S, Ottaviani S, Casalini G, Richardson PJ, et&#160;al. (Sacco Baricitinib Study Group) (August 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300657">"Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients"</a>. <i>EMBO Molecular Medicine</i>. <b>12</b> (8): e12697. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.15252%2Femmm.202012697">10.15252/emmm.202012697</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300657">7300657</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32473600">32473600</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EMBO+Molecular+Medicine&amp;rft.atitle=Mechanism+of+baricitinib+supports+artificial+intelligence-predicted+testing+in+COVID-19+patients&amp;rft.volume=12&amp;rft.issue=8&amp;rft.pages=e12697&amp;rft.date=2020-08&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7300657%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32473600&amp;rft_id=info%3Adoi%2F10.15252%2Femmm.202012697&amp;rft.aulast=Stebbing&amp;rft.aufirst=J&amp;rft.au=Krishnan%2C+V&amp;rft.au=de+Bono%2C+S&amp;rft.au=Ottaviani%2C+S&amp;rft.au=Casalini%2C+G&amp;rft.au=Richardson%2C+PJ&amp;rft.au=Monteil%2C+V&amp;rft.au=Lauschke%2C+VM&amp;rft.au=Mirazimi%2C+A&amp;rft.au=Youhanna%2C+S&amp;rft.au=Tan%2C+YJ&amp;rft.au=Baldanti%2C+F&amp;rft.au=Sarasini%2C+A&amp;rft.au=Terres%2C+JA&amp;rft.au=Nickoloff%2C+BJ&amp;rft.au=Higgs%2C+RE&amp;rft.au=Rocha%2C+G&amp;rft.au=Byers%2C+NL&amp;rft.au=Schlichting%2C+DE&amp;rft.au=Nirula%2C+A&amp;rft.au=Cardoso%2C+A&amp;rft.au=Corbellino%2C+M&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7300657&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li> <li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222"><cite id="CITEREFZhangZhangQiaoZhang2020" class="citation journal cs1">Zhang X, Zhang Y, Qiao W, Zhang J, Qi Z (September 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328558">"Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19"</a>. <i>International Immunopharmacology</i>. <b>86</b>: 106749. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.intimp.2020.106749">10.1016/j.intimp.2020.106749</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328558">7328558</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32645632">32645632</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Immunopharmacology&amp;rft.atitle=Baricitinib%2C+a+drug+with+potential+effect+to+prevent+SARS-COV-2+from+entering+target+cells+and+control+cytokine+storm+induced+by+COVID-19&amp;rft.volume=86&amp;rft.pages=106749&amp;rft.date=2020-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7328558%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32645632&amp;rft_id=info%3Adoi%2F10.1016%2Fj.intimp.2020.106749&amp;rft.aulast=Zhang&amp;rft.aufirst=X&amp;rft.au=Zhang%2C+Y&amp;rft.au=Qiao%2C+W&amp;rft.au=Zhang%2C+J&amp;rft.au=Qi%2C+Z&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7328558&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABaricitinib" class="Z3988"></span></li></ul> </div> <div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style></div><div role="navigation" class="navbox" aria-labelledby="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Immunosuppressants" title="Template:Immunosuppressants"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Immunosuppressants" title="Template talk:Immunosuppressants"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Immunosuppressants" title="Special:EditPage/Template:Immunosuppressants"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="font-size:114%;margin:0 4em"><a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">Immunosuppressive drugs</a>&#160;/ <a href="/wiki/Immunosuppression" title="Immunosuppression">Immunosuppressants</a> (<a href="/wiki/ATC_code_L04" title="ATC code L04">L04</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br />(initiation)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antimetabolite" title="Antimetabolite">Antimetabolites</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Purine_synthesis_inhibitor" class="mw-redirect" title="Purine synthesis inhibitor">purine synthesis inhibitors</a></i> <ul><li><a href="/wiki/Azathioprine" title="Azathioprine">Azathioprine</a></li> <li><a href="/wiki/Mycophenolic_acid" title="Mycophenolic acid">Mycophenolic acid</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Dihydroorotate_dehydrogenase" title="Dihydroorotate dehydrogenase">dihydroorotate dehydrogenase</a></i> inhibitors <ul><li><a href="/wiki/Leflunomide" title="Leflunomide">Leflunomide</a></li> <li><a href="/wiki/Teriflunomide" title="Teriflunomide">Teriflunomide</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Antifolate" title="Antifolate">antifolate</a></i> <ul><li><a href="/wiki/Methotrexate" title="Methotrexate">Methotrexate</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Macrolide" title="Macrolide">Macrolides</a>/<br />other <a href="/wiki/Interleukin_2" title="Interleukin 2">IL-2</a> inhibitors</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/FKBP" title="FKBP">FKBP</a>/<a href="/wiki/Cyclophilin" title="Cyclophilin">Cyclophilin</a>/<a href="/wiki/Calcineurin" title="Calcineurin">Calcineurin</a></i> <ul><li><a href="/wiki/Ciclosporin" title="Ciclosporin">Ciclosporin</a></li> <li><a href="/wiki/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li> <li><a href="/wiki/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li> <li><a href="/wiki/Voclosporin" title="Voclosporin">Voclosporin</a></li></ul></li></ul> <ul><li><a href="/wiki/Abetimus" title="Abetimus">Abetimus</a></li> <li><a href="/wiki/Gusperimus" title="Gusperimus">Gusperimus</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Immunomodulatory_imide_drug" class="mw-redirect" title="Immunomodulatory imide drug">IMiDs</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Lenalidomide" title="Lenalidomide">Lenalidomide</a></li> <li><a href="/wiki/Pomalidomide" title="Pomalidomide">Pomalidomide</a></li> <li><a href="/wiki/Thalidomide" title="Thalidomide">Thalidomide</a></li> <li><i><a href="/wiki/PDE4_inhibitor" title="PDE4 inhibitor">PDE4 inhibitor</a></i> <ul><li><a href="/wiki/Apremilast" title="Apremilast">Apremilast</a></li></ul></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br />(reception)</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Interleukin_1_receptor_antagonist" class="mw-redirect" title="Interleukin 1 receptor antagonist">IL-1 receptor antagonists</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Anakinra" title="Anakinra">Anakinra</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/MTOR" title="MTOR">mTOR</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Everolimus" title="Everolimus">Everolimus</a></li> <li><a href="/wiki/Ridaforolimus" title="Ridaforolimus">Ridaforolimus</a></li> <li><a href="/wiki/Sirolimus" title="Sirolimus">Sirolimus</a></li> <li><a href="/wiki/Temsirolimus" title="Temsirolimus">Temsirolimus</a></li> <li><a href="/wiki/Umirolimus" title="Umirolimus">Umirolimus</a></li> <li><a href="/wiki/Zotarolimus" title="Zotarolimus">Zotarolimus</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Extracellular</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Antibody" title="Antibody">Antibodies</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">Monoclonal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Serum target<br />(noncellular)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/Complement_component_5" title="Complement component 5">Complement component 5</a></i> <ul><li><a href="/wiki/Eculizumab" title="Eculizumab">Eculizumab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF</a></i> <ul><li><a href="/wiki/Adalimumab" title="Adalimumab">Adalimumab</a></li> <li><a href="/wiki/Afelimomab" title="Afelimomab">Afelimomab</a></li> <li><a href="/wiki/Certolizumab_pegol" title="Certolizumab pegol">Certolizumab pegol</a></li> <li><a href="/wiki/Golimumab" title="Golimumab">Golimumab</a></li> <li><a href="/wiki/Infliximab" title="Infliximab">Infliximab</a></li> <li><a href="/wiki/Nerelimomab" title="Nerelimomab">Nerelimomab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interleukin" title="Interleukin">Interleukin</a></i> <ul><li><a href="/wiki/Anakinra" title="Anakinra">Anakinra</a></li> <li><a href="/wiki/Basiliximab" title="Basiliximab">Basiliximab</a></li> <li><a href="/wiki/Bimekizumab" title="Bimekizumab">Bimekizumab</a></li> <li><a href="/wiki/Briakinumab" title="Briakinumab">Briakinumab</a></li> <li><a href="/wiki/Brodalumab" title="Brodalumab">Brodalumab</a></li> <li><a href="/wiki/Canakinumab" title="Canakinumab">Canakinumab</a></li> <li><a href="/wiki/Daclizumab" title="Daclizumab">Daclizumab</a></li> <li><a href="/wiki/Guselkumab" title="Guselkumab">Guselkumab</a></li> <li><a href="/wiki/Ixekizumab" title="Ixekizumab">Ixekizumab</a></li> <li><a href="/w/index.php?title=Netakimab&amp;action=edit&amp;redlink=1" class="new" title="Netakimab (page does not exist)">Netakimab</a></li> <li><a href="/wiki/Olokizumab" title="Olokizumab">Olokizumab</a></li> <li><a href="/wiki/Rilonacept" title="Rilonacept">Rilonacept</a></li> <li><a href="/wiki/Risankizumab" title="Risankizumab">Risankizumab</a></li> <li><a href="/wiki/Sarilumab" title="Sarilumab">Sarilumab</a></li> <li><a href="/wiki/Satralizumab" title="Satralizumab">Satralizumab</a></li> <li><a href="/wiki/Secukinumab" title="Secukinumab">Secukinumab</a></li> <li><a href="/wiki/Siltuximab" title="Siltuximab">Siltuximab</a></li> <li><a href="/wiki/Sirukumab" title="Sirukumab">Sirukumab</a></li> <li><a href="/wiki/Spesolimab" title="Spesolimab">Spesolimab</a></li> <li><a href="/wiki/Tildrakizumab" title="Tildrakizumab">Tildrakizumab</a></li> <li><a href="/wiki/Tocilizumab" title="Tocilizumab">Tocilizumab</a></li> <li><a href="/wiki/Ustekinumab" title="Ustekinumab">Ustekinumab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interleukin_5" title="Interleukin 5">Interleukin 5</a></i> <ul><li><a href="/wiki/Mepolizumab" title="Mepolizumab">Mepolizumab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Immunoglobulin_E" title="Immunoglobulin E">Immunoglobulin E</a></i> <ul><li><a href="/wiki/Omalizumab" title="Omalizumab">Omalizumab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interferon" title="Interferon">Interferon</a></i> <ul><li><a href="/wiki/Faralimomab" title="Faralimomab">Faralimomab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interleukin_6" title="Interleukin 6">IL-6</a></i> <ul><li><a href="/wiki/Elsilimomab" title="Elsilimomab">Elsilimomab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interleukin_12" title="Interleukin 12">IL-12</a>, <a href="/wiki/Interleukin_13" title="Interleukin 13">IL-13</a>, and <a href="/wiki/Interleukin_23" title="Interleukin 23">IL-23</a></i> <ul><li><a href="/wiki/Lebrikizumab" title="Lebrikizumab">Lebrikizumab</a></li> <li><a href="/wiki/Ustekinumab" title="Ustekinumab">Ustekinumab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/Interleukin_17" title="Interleukin 17">IL-17A</a></i> <ul><li><a href="/wiki/Secukinumab" title="Secukinumab">Secukinumab</a></li></ul></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cellular<br />target</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a></i> <ul><li><a href="/wiki/Muromonab-CD3" title="Muromonab-CD3">Muromonab-CD3</a></li> <li><a href="/wiki/Otelixizumab" title="Otelixizumab">Otelixizumab</a></li> <li><a href="/wiki/Teplizumab" title="Teplizumab">Teplizumab</a></li> <li><a href="/wiki/Visilizumab" title="Visilizumab">Visilizumab</a></li></ul></li> <li><i><a href="/wiki/CD4" title="CD4">CD4</a></i> <ul><li><a href="/wiki/Clenoliximab" title="Clenoliximab">Clenoliximab</a></li> <li><a href="/wiki/Keliximab" title="Keliximab">Keliximab</a></li> <li><a href="/wiki/Zanolimumab" title="Zanolimumab">Zanolimumab</a></li></ul></li> <li><i><a href="/wiki/CD11a" class="mw-redirect" title="CD11a">CD11a</a></i> <ul><li><a href="/wiki/Efalizumab" title="Efalizumab">Efalizumab</a></li></ul></li> <li><i><a href="/wiki/CD18" class="mw-redirect" title="CD18">CD18</a></i> <ul><li><a href="/wiki/Erlizumab" title="Erlizumab">Erlizumab</a></li></ul></li> <li><i><a href="/wiki/CD20" title="CD20">CD20</a></i> <ul><li><a href="/wiki/Obinutuzumab" title="Obinutuzumab">Obinutuzumab</a></li> <li><a href="/wiki/Ocrelizumab" title="Ocrelizumab">Ocrelizumab</a> (<a href="/wiki/Ocrelizumab/hyaluronidase" title="Ocrelizumab/hyaluronidase">+hyaluronidase</a>)</li> <li><a href="/wiki/Pascolizumab" title="Pascolizumab">Pascolizumab</a></li> <li><a href="/wiki/Rituximab" title="Rituximab">Rituximab</a></li> <li><a href="/wiki/Ublituximab" title="Ublituximab">Ublituximab</a></li></ul></li> <li><i><a href="/wiki/CD23" title="CD23">CD23</a></i> <ul><li><a href="/wiki/Gomiliximab" class="mw-redirect" title="Gomiliximab">Gomiliximab</a></li> <li><a href="/wiki/Lumiliximab" title="Lumiliximab">Lumiliximab</a></li></ul></li> <li><i><a href="/wiki/CD40_(protein)" title="CD40 (protein)">CD40</a></i> <ul><li><a href="/wiki/Teneliximab" title="Teneliximab">Teneliximab</a></li> <li><a href="/wiki/Toralizumab" title="Toralizumab">Toralizumab</a></li></ul></li> <li><i><a href="/wiki/L-selectin" title="L-selectin">CD62L/L-selectin</a></i> <ul><li><a href="/wiki/Aselizumab" title="Aselizumab">Aselizumab</a></li></ul></li> <li><i><a href="/wiki/CD80" title="CD80">CD80</a></i> <ul><li><a href="/wiki/Galiximab" title="Galiximab">Galiximab</a></li></ul></li> <li><i><a href="/wiki/Basigin" title="Basigin">CD147/Basigin</a></i> <ul><li><a href="/wiki/Gavilimomab" title="Gavilimomab">Gavilimomab</a></li></ul></li> <li><i><a href="/wiki/CD154" title="CD154">CD154</a></i> <ul><li><a href="/wiki/Frexalimab" title="Frexalimab">Frexalimab</a></li> <li><a href="/wiki/Ruplizumab" title="Ruplizumab">Ruplizumab</a></li></ul></li></ul> <ul><li><i>BLyS</i> <ul><li><a href="/wiki/Belimumab" title="Belimumab">Belimumab</a></li></ul></li> <li><i><a href="/wiki/Chloramphenicol_acetyltransferase" title="Chloramphenicol acetyltransferase">CAT</a></i> <ul><li><a href="/wiki/Bertilimumab" title="Bertilimumab">Bertilimumab</a></li> <li><a href="/wiki/Lerdelimumab" title="Lerdelimumab">Lerdelimumab</a></li> <li><a href="/wiki/Metelimumab" title="Metelimumab">Metelimumab</a></li></ul></li> <li><i><a href="/wiki/Integrin" title="Integrin">Integrin</a></i> <ul><li><a href="/wiki/Natalizumab" title="Natalizumab">Natalizumab</a></li> <li><a href="/wiki/Vedolizumab" title="Vedolizumab">Vedolizumab</a></li></ul></li> <li><i><a href="/wiki/Interleukin-6_receptor" title="Interleukin-6 receptor">Interleukin-6 receptor</a></i> <ul><li><a href="/wiki/Tocilizumab" title="Tocilizumab">Tocilizumab</a></li></ul></li> <li><i><a href="/wiki/Lymphocyte_function-associated_antigen_1" title="Lymphocyte function-associated antigen 1">LFA-1</a></i> <ul><li><a href="/wiki/Odulimomab" title="Odulimomab">Odulimomab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/IL-2_receptor" title="IL-2 receptor">IL-2 receptor/CD25</a></i> <ul><li><a href="/wiki/Basiliximab" title="Basiliximab">Basiliximab</a></li> <li><a href="/wiki/Daclizumab" title="Daclizumab">Daclizumab</a></li> <li><a href="/wiki/Inolimomab" title="Inolimomab">Inolimomab</a></li></ul></li></ul> <ul><li><i><a href="/wiki/T_cell" title="T cell">T-lymphocyte</a></i> (<a href="/wiki/Zolimomab_aritox" title="Zolimomab aritox">Zolimomab aritox</a>)</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unsorted</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Alemtuzumab" title="Alemtuzumab">Alemtuzumab</a></li> <li><a href="/wiki/Anifrolumab" title="Anifrolumab">Anifrolumab</a></li> <li><a href="/wiki/Atorolimumab" title="Atorolimumab">Atorolimumab</a></li> <li><a href="/w/index.php?title=Begelomab&amp;action=edit&amp;redlink=1" class="new" title="Begelomab (page does not exist)">Begelomab</a></li> <li><a href="/wiki/Cedelizumab" title="Cedelizumab">Cedelizumab</a></li> <li><a href="/wiki/Emapalumab" title="Emapalumab">Emapalumab</a></li> <li><a href="/wiki/Fontolizumab" title="Fontolizumab">Fontolizumab</a></li> <li><a href="/wiki/Inebilizumab" title="Inebilizumab">Inebilizumab</a></li> <li><a href="/wiki/Maslimomab" title="Maslimomab">Maslimomab</a></li> <li><a href="/wiki/Morolimumab" title="Morolimumab">Morolimumab</a></li> <li><a href="/wiki/Ofatumumab" title="Ofatumumab">Ofatumumab</a></li> <li><a href="/wiki/Pexelizumab" title="Pexelizumab">Pexelizumab</a></li> <li><a href="/wiki/Reslizumab" title="Reslizumab">Reslizumab</a></li> <li><a href="/wiki/Rovelizumab" title="Rovelizumab">Rovelizumab</a></li> <li><a href="/wiki/Siplizumab" title="Siplizumab">Siplizumab</a></li> <li><a href="/wiki/Talizumab" title="Talizumab">Talizumab</a></li> <li><a href="/wiki/Telimomab_aritox" title="Telimomab aritox">Telimomab aritox</a></li> <li><a href="/wiki/Teprotumumab" title="Teprotumumab">Teprotumumab</a></li> <li><a href="/wiki/Vapaliximab" title="Vapaliximab">Vapaliximab</a></li> <li><a href="/wiki/Vepalimomab" title="Vepalimomab">Vepalimomab</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Polyclonal_antibodies" title="Polyclonal antibodies">Polyclonal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Anti-thymocyte_globulin" title="Anti-thymocyte globulin">Anti-thymocyte globulin</a></li> <li><a href="/wiki/Anti-lymphocyte_globulin" title="Anti-lymphocyte globulin">Anti-lymphocyte globulin</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-cept (<a href="/wiki/Fusion_protein" title="Fusion protein">Fusion</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i><a href="/wiki/CTLA-4" class="mw-redirect" title="CTLA-4">CTLA-4</a></i> <ul><li><a href="/wiki/Abatacept" title="Abatacept">Abatacept</a></li> <li><a href="/wiki/Belatacept" title="Belatacept">Belatacept</a></li></ul></li> <li><i><a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitor</a></i> <ul><li><a href="/wiki/Etanercept" title="Etanercept">Etanercept</a></li> <li><a href="/w/index.php?title=Opinercept&amp;action=edit&amp;redlink=1" class="new" title="Opinercept (page does not exist)">Opinercept</a></li></ul></li> <li><a href="/wiki/Aflibercept" title="Aflibercept">Aflibercept</a></li> <li><a href="/wiki/Alefacept" title="Alefacept">Alefacept</a></li> <li><a href="/wiki/Rilonacept" title="Rilonacept">Rilonacept</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unsorted</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Avacopan" title="Avacopan">Avacopan</a></li> <li><a class="mw-selflink selflink">Baricitinib</a></li> <li><a href="/wiki/Bimekizumab" title="Bimekizumab">Bimekizumab</a></li> <li><a href="/wiki/Blisibimod" title="Blisibimod">Blisibimod</a></li> <li><a href="/wiki/Briakinumab" title="Briakinumab">Briakinumab</a></li> <li><a href="/wiki/Brodalumab" title="Brodalumab">Brodalumab</a></li> <li><a href="/wiki/Canakinumab" title="Canakinumab">Canakinumab</a></li> <li><a href="/wiki/Crovalimab" title="Crovalimab">Crovalimab</a></li> <li><a href="/wiki/Danicopan" title="Danicopan">Danicopan</a></li> <li><a href="/wiki/Darvadstrocel" title="Darvadstrocel">Darvadstrocel</a></li> <li><a href="/wiki/Deucravacitinib" title="Deucravacitinib">Deucravacitinib</a></li> <li><a href="/wiki/Deuruxolitinib" title="Deuruxolitinib">Deuruxolitinib</a></li> <li><a href="/wiki/Dimethyl_fumarate" title="Dimethyl fumarate">Dimethyl fumarate</a></li> <li><a href="/wiki/Diroximel_fumarate" title="Diroximel fumarate">Diroximel fumarate</a></li> <li><a href="/wiki/Efgartigimod_alfa" title="Efgartigimod alfa">Efgartigimod alfa</a> (<a href="/wiki/Efgartigimod_alfa/hyaluronidase" title="Efgartigimod alfa/hyaluronidase">+hyaluronidase</a>)</li> <li><a href="/wiki/Etrasimod" title="Etrasimod">Etrasimod</a></li> <li><a href="/wiki/Filgotinib" title="Filgotinib">Filgotinib</a></li> <li><a href="/wiki/Fingolimod" title="Fingolimod">Fingolimod</a></li> <li><a href="/wiki/Guselkumab" title="Guselkumab">Guselkumab</a></li> <li><a href="/wiki/Iptacopan" title="Iptacopan">Iptacopan</a></li> <li><a href="/w/index.php?title=Itacitinib&amp;action=edit&amp;redlink=1" class="new" title="Itacitinib (page does not exist)">Itacitinib</a></li> <li><a href="/wiki/Ixekizumab" title="Ixekizumab">Ixekizumab</a></li> <li><a href="/w/index.php?title=Netakimab&amp;action=edit&amp;redlink=1" class="new" title="Netakimab (page does not exist)">Netakimab</a></li> <li><a href="/wiki/Olokizumab" title="Olokizumab">Olokizumab</a></li> <li><a href="/wiki/Ozanimod" title="Ozanimod">Ozanimod</a></li> <li><a href="/wiki/Peficitinib" title="Peficitinib">Peficitinib</a></li> <li><a href="/wiki/Pegcetacoplan" title="Pegcetacoplan">Pegcetacoplan</a></li> <li><a href="/wiki/Pirfenidone" title="Pirfenidone">Pirfenidone</a></li> <li><a href="/wiki/Ponesimod" title="Ponesimod">Ponesimod</a></li> <li><a href="/wiki/Ravulizumab" title="Ravulizumab">Ravulizumab</a></li> <li><a href="/wiki/Risankizumab" title="Risankizumab">Risankizumab</a></li> <li><a href="/wiki/Ritlecitinib" title="Ritlecitinib">Ritlecitinib</a></li> <li><a href="/wiki/Rozanolixizumab" title="Rozanolixizumab">Rozanolixizumab</a></li> <li><a href="/wiki/Sarilumab" title="Sarilumab">Sarilumab</a></li> <li><a href="/wiki/Satralizumab" title="Satralizumab">Satralizumab</a></li> <li><a href="/wiki/Siltuximab" title="Siltuximab">Siltuximab</a></li> <li><a href="/wiki/Siponimod" title="Siponimod">Siponimod</a></li> <li><a href="/wiki/Sirukumab" title="Sirukumab">Sirukumab</a></li> <li><a href="/wiki/Spesolimab" title="Spesolimab">Spesolimab</a></li> <li><a href="/wiki/Sutimlimab" title="Sutimlimab">Sutimlimab</a></li> <li><a href="/wiki/Telitacicept" title="Telitacicept">Telitacicept</a></li> <li><a href="/wiki/Tildrakizumab" title="Tildrakizumab">Tildrakizumab</a></li> <li><a href="/wiki/Tofacitinib" title="Tofacitinib">Tofacitinib</a></li> <li><a href="/wiki/Upadacitinib" title="Upadacitinib">Upadacitinib</a></li></ul> </div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Cytokine_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Cytokine_receptor_modulators" title="Template:Cytokine receptor modulators"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Cytokine_receptor_modulators" title="Template talk:Cytokine receptor modulators"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Cytokine_receptor_modulators" title="Special:EditPage/Template:Cytokine receptor modulators"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Cytokine_receptor_modulators" style="font-size:114%;margin:0 4em"><a href="/wiki/Cytokine_receptor" title="Cytokine receptor">Cytokine receptor</a> <a href="/wiki/Receptor_modulator" title="Receptor modulator">modulators</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Chemokine_receptor" title="Chemokine receptor">Chemokine</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See <a href="/wiki/Template:Chemokine_receptor_modulators" title="Template:Chemokine receptor modulators">here</a> instead.</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Colony-stimulating_factor_receptor" class="mw-redirect" title="Colony-stimulating factor receptor">CSF</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Erythropoietin_receptor" title="Erythropoietin receptor">Erythropoietin</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/w/index.php?title=ARA-290&amp;action=edit&amp;redlink=1" class="new" title="ARA-290 (page does not exist)">ARA-290</a></li> <li><a href="/w/index.php?title=Asialo_erythropoietin&amp;action=edit&amp;redlink=1" class="new" title="Asialo erythropoietin (page does not exist)">Asialo erythropoietin</a></li> <li><a href="/w/index.php?title=Carbamylated_erythropoietin&amp;action=edit&amp;redlink=1" class="new" title="Carbamylated erythropoietin (page does not exist)">Carbamylated erythropoietin</a></li> <li><a href="/w/index.php?title=CNTO-530&amp;action=edit&amp;redlink=1" class="new" title="CNTO-530 (page does not exist)">CNTO-530</a></li> <li><a href="/wiki/Darbepoetin_alfa" title="Darbepoetin alfa">Darbepoetin alfa</a></li> <li><a href="/wiki/Epoetin_alfa" title="Epoetin alfa">Epoetin alfa</a></li> <li><a href="/wiki/Epoetin_beta" title="Epoetin beta">Epoetin beta</a></li> <li><a href="/w/index.php?title=Epoetin_delta&amp;action=edit&amp;redlink=1" class="new" title="Epoetin delta (page does not exist)">Epoetin delta</a></li> <li><a href="/w/index.php?title=Epoetin_epsilon&amp;action=edit&amp;redlink=1" class="new" title="Epoetin epsilon (page does not exist)">Epoetin epsilon</a></li> <li><a href="/w/index.php?title=Epoetin_gamma&amp;action=edit&amp;redlink=1" class="new" title="Epoetin gamma (page does not exist)">Epoetin gamma</a></li> <li><a href="/w/index.php?title=Epoetin_kappa&amp;action=edit&amp;redlink=1" class="new" title="Epoetin kappa (page does not exist)">Epoetin kappa</a></li> <li><a href="/w/index.php?title=Epoetin_omega&amp;action=edit&amp;redlink=1" class="new" title="Epoetin omega (page does not exist)">Epoetin omega</a></li> <li><a href="/wiki/Epoetin_theta" title="Epoetin theta">Epoetin theta</a></li> <li><a href="/wiki/Epoetin_zeta" class="mw-redirect" title="Epoetin zeta">Epoetin zeta</a></li> <li><a href="/wiki/Erythropoietin" title="Erythropoietin">Erythropoietin (EPO)</a></li> <li><a href="/w/index.php?title=Erythropoietin-Fc&amp;action=edit&amp;redlink=1" class="new" title="Erythropoietin-Fc (page does not exist)">Erythropoietin-Fc</a></li> <li><a href="/wiki/Methoxy_polyethylene_glycol-epoetin_beta" title="Methoxy polyethylene glycol-epoetin beta">Methoxy polyethylene glycol-epoetin beta (CERA/Mircera)</a></li> <li><a href="/wiki/Peginesatide" title="Peginesatide">Peginesatide</a></li> <li><a href="/w/index.php?title=Pegol_sihematide&amp;action=edit&amp;redlink=1" class="new" title="Pegol sihematide (page does not exist)">Pegol sihematide (EPO-018B)</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Granulocyte_colony-stimulating_factor_receptor" title="Granulocyte colony-stimulating factor receptor">G-CSF (CSF3)</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Filgrastim" title="Filgrastim">Filgrastim</a></li> <li><a href="/wiki/Granulocyte_colony-stimulating_factor" title="Granulocyte colony-stimulating factor">Granulocyte colony-stimulating factor</a></li> <li><a href="/wiki/Lenograstim" title="Lenograstim">Lenograstim</a></li> <li><a href="/w/index.php?title=Leridistim&amp;action=edit&amp;redlink=1" class="new" title="Leridistim (page does not exist)">Leridistim</a></li> <li><a href="/wiki/Lipegfilgrastim" title="Lipegfilgrastim">Lipegfilgrastim</a></li> <li><a href="/w/index.php?title=Nartograstim&amp;action=edit&amp;redlink=1" class="new" title="Nartograstim (page does not exist)">Nartograstim</a></li> <li><a href="/wiki/Pegfilgrastim" title="Pegfilgrastim">Pegfilgrastim</a></li> <li><a href="/w/index.php?title=Pegnartograstim&amp;action=edit&amp;redlink=1" class="new" title="Pegnartograstim (page does not exist)">Pegnartograstim</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Granulocyte_macrophage_colony-stimulating_factor_receptor" class="mw-redirect" title="Granulocyte macrophage colony-stimulating factor receptor">GM-CSF (CSF2)</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/w/index.php?title=Ecogramostim&amp;action=edit&amp;redlink=1" class="new" title="Ecogramostim (page does not exist)">Ecogramostim</a></li> <li><a href="/wiki/Granulocyte_macrophage_colony-stimulating_factor" class="mw-redirect" title="Granulocyte macrophage colony-stimulating factor">Granulocyte macrophage colony-stimulating factor</a></li> <li><a href="/w/index.php?title=Milodistim&amp;action=edit&amp;redlink=1" class="new" title="Milodistim (page does not exist)">Milodistim</a></li> <li><a href="/wiki/Molgramostim" title="Molgramostim">Molgramostim</a></li> <li><a href="/w/index.php?title=Regramostim&amp;action=edit&amp;redlink=1" class="new" title="Regramostim (page does not exist)">Regramostim</a></li> <li><a href="/wiki/Sargramostim" title="Sargramostim">Sargramostim</a></li></ul> <ul><li><i>Antibodies:</i> <a href="/wiki/Mavrilimumab" title="Mavrilimumab">Mavrilimumab</a></li> <li><a href="/wiki/Namilumab" title="Namilumab">Namilumab</a></li> <li><a href="/wiki/Otilimab" title="Otilimab">Otilimab</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Macrophage_colony-stimulating_factor_receptor" class="mw-redirect" title="Macrophage colony-stimulating factor receptor">M-CSF (CSF1)</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/w/index.php?title=Cilmostim&amp;action=edit&amp;redlink=1" class="new" title="Cilmostim (page does not exist)">Cilmostim</a></li> <li><a href="/wiki/Interleukin-34" class="mw-redirect" title="Interleukin-34">Interleukin-34</a></li> <li><a href="/w/index.php?title=Lanimostim&amp;action=edit&amp;redlink=1" class="new" title="Lanimostim (page does not exist)">Lanimostim</a></li> <li><a href="/wiki/Macrophage_colony-stimulating_factor" title="Macrophage colony-stimulating factor">Macrophage colony-stimulating factor</a></li> <li><a href="/w/index.php?title=Mirimostim&amp;action=edit&amp;redlink=1" class="new" title="Mirimostim (page does not exist)">Mirimostim</a></li></ul> <ul><li><i>Kinase inhibitors:</i> <a href="/w/index.php?title=Agerafenib&amp;action=edit&amp;redlink=1" class="new" title="Agerafenib (page does not exist)">Agerafenib</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/CD117" class="mw-redirect" title="CD117">SCF (c-Kit)</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See <a href="/wiki/Template:Growth_factor_receptor_modulators" title="Template:Growth factor receptor modulators">here</a> instead.</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Thrombopoietin_receptor" title="Thrombopoietin receptor">Thrombopoietin</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Eltrombopag" title="Eltrombopag">Eltrombopag</a></li> <li><a href="/w/index.php?title=Pegacaristim&amp;action=edit&amp;redlink=1" class="new" title="Pegacaristim (page does not exist)">Pegacaristim</a></li> <li><a href="/wiki/Promegapoietin" title="Promegapoietin">Promegapoietin</a></li> <li><a href="/wiki/Romiplostim" title="Romiplostim">Romiplostim</a></li> <li><a href="/wiki/Thrombopoietin" title="Thrombopoietin">Thrombopoietin (THPO, MGDF)</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Interferon_receptor" class="mw-redirect" title="Interferon receptor">Interferon</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Interferon-alpha/beta_receptor" title="Interferon-alpha/beta receptor">IFNAR (α/β, I)</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Albinterferon" title="Albinterferon">Albinterferon</a></li> <li><a href="/wiki/Interferon_alpha" class="mw-redirect" title="Interferon alpha">Interferon alpha (interferon alfa, IFN-α)</a></li> <li><a href="/wiki/Interferon_alfa" title="Interferon alfa">Interferon alfa</a> (<a href="/wiki/Interferon_alpha_1" class="mw-redirect" title="Interferon alpha 1">IFNA1</a>, <a href="/wiki/IFNA2" title="IFNA2">IFNA2</a>, <a href="/wiki/IFNA4" title="IFNA4">IFNA4</a>, <a href="/wiki/IFNA5" title="IFNA5">IFNA5</a>, <a href="/wiki/IFNA6" title="IFNA6">IFNA6</a>, <a href="/wiki/IFNA7" title="IFNA7">IFNA7</a>, <a href="/wiki/IFNA8" title="IFNA8">IFNA8</a>, <a href="/wiki/IFNA10" title="IFNA10">IFNA10</a>, <a href="/wiki/IFNA13" title="IFNA13">IFNA13</a>, <a href="/wiki/IFNA14" title="IFNA14">IFNA14</a>, <a href="/wiki/IFNA16" title="IFNA16">IFNA16</a>, <a href="/wiki/IFNA17" title="IFNA17">IFNA17</a>, <a href="/wiki/IFNA21" title="IFNA21">IFNA21</a>)</li> <li><a href="/wiki/Interferon_alfa_2a" class="mw-redirect" title="Interferon alfa 2a">Interferon alfa 2a</a></li> <li><a href="/wiki/Interferon_alfa_2b" class="mw-redirect" title="Interferon alfa 2b">Interferon alfa 2b</a></li> <li><a href="/w/index.php?title=Interferon_alfa_n1&amp;action=edit&amp;redlink=1" class="new" title="Interferon alfa n1 (page does not exist)">Interferon alfa n1</a></li> <li><a href="/wiki/Interferon_alfacon-1" title="Interferon alfacon-1">Interferon alfacon-1</a></li> <li><a href="/wiki/Interferon_alpha-n3" title="Interferon alpha-n3">Interferon alpha-n3</a></li> <li><a href="/wiki/Interferon_beta" class="mw-redirect" title="Interferon beta">Interferon beta (IFN-β)</a> (<a href="/wiki/IFNB1" title="IFNB1">IFNB1</a>, <a href="/w/index.php?title=IFNB3&amp;action=edit&amp;redlink=1" class="new" title="IFNB3 (page does not exist)">IFNB3</a>)</li> <li><a href="/wiki/Interferon_beta_1a" class="mw-redirect" title="Interferon beta 1a">Interferon beta 1a</a></li> <li><a href="/wiki/Interferon_beta_1b" class="mw-redirect" title="Interferon beta 1b">Interferon beta 1b</a></li> <li><a href="/wiki/Interferon_kappa" class="mw-redirect" title="Interferon kappa">Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)</a></li> <li><a href="/wiki/Interferon_omega" class="mw-redirect" title="Interferon omega">Interferon omega (IFN-ω, IFNW1)</a></li> <li><a href="/wiki/Peginterferon_alfa-2a" title="Peginterferon alfa-2a">Peginterferon alfa-2a</a></li> <li><a href="/wiki/Peginterferon_alfa-2b" title="Peginterferon alfa-2b">Peginterferon alfa-2b</a></li></ul> <ul><li><i>Antibodies:</i> <a href="/wiki/Anifrolumab" title="Anifrolumab">Anifrolumab</a></li> <li><a href="/wiki/Faralimomab" title="Faralimomab">Faralimomab</a></li> <li><a href="/w/index.php?title=MEDI-545&amp;action=edit&amp;redlink=1" class="new" title="MEDI-545 (page does not exist)">MEDI-545</a></li> <li><a href="/wiki/Rontalizumab" title="Rontalizumab">Rontalizumab</a></li> <li><a href="/wiki/Sifalimumab" title="Sifalimumab">Sifalimumab</a></li></ul> <ul><li><i>Decoy receptors:</i> <a href="/w/index.php?title=Bifarcept&amp;action=edit&amp;redlink=1" class="new" title="Bifarcept (page does not exist)">Bifarcept</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Interferon-gamma_receptor" title="Interferon-gamma receptor">IFNGR (γ, II)</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Agonists:</i> <a href="/wiki/Interferon_gamma" title="Interferon gamma">Interferon gamma (IFN-γ)</a></li> <li><a href="/wiki/Interferon_gamma_1b" class="mw-redirect" title="Interferon gamma 1b">Interferon gamma 1b</a></li></ul> <ul><li><i>Antibodies:</i> <a href="/wiki/Emapalumab" title="Emapalumab">Emapalumab</a></li> <li><a href="/wiki/Fontolizumab" title="Fontolizumab">Fontolizumab</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Interferon-lambda_receptor" class="mw-redirect" title="Interferon-lambda receptor">IFNLR (λ, III)</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See IL-28R (IFNLR) <a href="/wiki/Template:Interleukin_receptor_modulators" title="Template:Interleukin receptor modulators">here</a> instead.</li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Interleukin_receptor" title="Interleukin receptor">Interleukin</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See <a href="/wiki/Template:Interleukin_receptor_modulators" title="Template:Interleukin receptor modulators">here</a> instead.</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Transforming_growth_factor_beta_receptor" class="mw-redirect" title="Transforming growth factor beta receptor">TGFβ</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See <a href="/wiki/Template:TGF%CE%B2_receptor_superfamily_modulators" title="Template:TGFβ receptor superfamily modulators">here</a> instead.</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Tumor_necrosis_factor_receptor" class="mw-redirect" title="Tumor necrosis factor receptor">TNF</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li>See <a href="/wiki/Template:TNF_receptor_superfamily_modulators" title="Template:TNF receptor superfamily modulators">here</a> instead.</li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Janus_kinase" title="Janus kinase">JAK</a><br /><small>(<a href="/wiki/Janus_kinase_inhibitor" title="Janus kinase inhibitor">inhibitors</a>)</small></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/JAK1" class="mw-redirect" title="JAK1">JAK1</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Abrocitinib" title="Abrocitinib">Abrocitinib</a></li> <li><a class="mw-selflink selflink">Baricitinib</a></li> <li><a href="/wiki/Deuruxolitinib" title="Deuruxolitinib">Deuruxolitinib</a></li> <li><a href="/wiki/Filgotinib" title="Filgotinib">Filgotinib</a></li> <li><a href="/wiki/Momelotinib" title="Momelotinib">Momelotinib</a></li> <li><a href="/wiki/Oclacitinib" title="Oclacitinib">Oclacitinib</a></li> <li><a href="/wiki/Peficitinib" title="Peficitinib">Peficitinib</a></li> <li><a href="/wiki/Ruxolitinib" title="Ruxolitinib">Ruxolitinib</a></li> <li><a href="/wiki/Tofacitinib" title="Tofacitinib">Tofacitinib (tasocitinib)</a></li> <li><a href="/wiki/Upadacitinib" title="Upadacitinib">Upadacitinib</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/JAK2" class="mw-redirect" title="JAK2">JAK2</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Atiprimod" title="Atiprimod">Atiprimod</a></li> <li><a href="/w/index.php?title=AZD-1480&amp;action=edit&amp;redlink=1" class="new" title="AZD-1480 (page does not exist)">AZD-1480</a></li> <li><a class="mw-selflink selflink">Baricitinib</a></li> <li><a href="/wiki/CHZ868" title="CHZ868">CHZ868</a></li> <li><a href="/wiki/Cucurbitacin_I" class="mw-redirect" title="Cucurbitacin I">Cucurbitacin I (elatericin B, JSI-124)</a></li> <li><a href="/wiki/CYT387" class="mw-redirect" title="CYT387">CYT387</a></li> <li><a href="/wiki/Deuruxolitinib" title="Deuruxolitinib">Deuruxolitinib</a></li> <li><a href="/wiki/Lestaurtinib" title="Lestaurtinib">Lestaurtinib</a></li> <li><a href="/w/index.php?title=NSC-7908&amp;action=edit&amp;redlink=1" class="new" title="NSC-7908 (page does not exist)">NSC-7908</a></li> <li><a href="/w/index.php?title=NSC-33994&amp;action=edit&amp;redlink=1" class="new" title="NSC-33994 (page does not exist)">NSC-33994</a></li> <li><a href="/wiki/Pacritinib" title="Pacritinib">Pacritinib</a></li> <li><a href="/wiki/Peficitinib" title="Peficitinib">Peficitinib</a></li> <li><a href="/wiki/Ruxolitinib" title="Ruxolitinib">Ruxolitinib</a></li> <li><a href="/w/index.php?title=SD-1008&amp;action=edit&amp;redlink=1" class="new" title="SD-1008 (page does not exist)">SD-1008</a></li> <li><a href="/wiki/Tofacitinib" title="Tofacitinib">Tofacitinib (tasocitinib)</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/JAK3" class="mw-redirect" title="JAK3">JAK3</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/w/index.php?title=Cercosporamide&amp;action=edit&amp;redlink=1" class="new" title="Cercosporamide (page does not exist)">Cercosporamide</a></li> <li><a href="/wiki/Decernotinib" title="Decernotinib">Decernotinib (VX-509)</a></li> <li><a href="/wiki/Peficitinib" title="Peficitinib">Peficitinib</a></li> <li><a href="/wiki/Ritlecitinib" title="Ritlecitinib">Ritlecitinib</a></li> <li><a href="/w/index.php?title=TCS-21311&amp;action=edit&amp;redlink=1" class="new" title="TCS-21311 (page does not exist)">TCS-21311</a></li> <li><a href="/wiki/Tofacitinib" title="Tofacitinib">Tofacitinib (tasocitinib)</a></li> <li><a href="/w/index.php?title=WHI-P_154&amp;action=edit&amp;redlink=1" class="new" title="WHI-P 154 (page does not exist)">WHI-P 154</a></li> <li><a href="/w/index.php?title=ZM-39923&amp;action=edit&amp;redlink=1" class="new" title="ZM-39923 (page does not exist)">ZM-39923</a></li> <li><a href="/w/index.php?title=ZM-449829&amp;action=edit&amp;redlink=1" class="new" title="ZM-449829 (page does not exist)">ZM-449829</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><a href="/wiki/Tyrosine_kinase_2" title="Tyrosine kinase 2">TYK2</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Deucravacitinib" title="Deucravacitinib">Deucravacitinib</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><i>Additional cytokines:</i> <a href="/wiki/Cardiotrophin_1" title="Cardiotrophin 1">Cardiotrophin 1 (CT-1)</a></li> <li><a href="/wiki/FMS-like_tyrosine_kinase_3_ligand" title="FMS-like tyrosine kinase 3 ligand">FMS-like tyrosine kinase 3 ligand (FLT3L)</a></li> <li><a href="/wiki/Leukemia_inhibitory_factor" title="Leukemia inhibitory factor">Leukemia/leukocyte inhibitory factor (LIF)</a></li> <li><a href="/wiki/Oncostatin_M" title="Oncostatin M">Oncostatin M (OSM)</a></li> <li><a href="/wiki/Thymic_stromal_lymphopoietin" title="Thymic stromal lymphopoietin">Thymic stromal lymphopoietin (TSLP)</a></li></ul> <ul><li><i>Additional cytokine receptor modulators:</i> <a href="/w/index.php?title=Emfilermin&amp;action=edit&amp;redlink=1" class="new" title="Emfilermin (page does not exist)">Emfilermin</a></li> <li><a href="/wiki/Lestaurtinib" title="Lestaurtinib">Lestaurtinib</a></li> <li><a href="/wiki/Midostaurin" title="Midostaurin">Midostaurin</a></li> <li><a href="/wiki/Quizartinib" title="Quizartinib">Quizartinib</a></li> <li><a href="/wiki/Sorafenib" title="Sorafenib">Sorafenib</a></li> <li><a href="/wiki/Sunitinib" title="Sunitinib">Sunitinib</a></li></ul> </div></td></tr></tbody></table><div></div></td></tr></tbody></table></div> <div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235"></div><div role="navigation" class="navbox" aria-labelledby="Eli_Lilly_and_Company" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231"><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Eli_Lilly_and_Company" title="Template:Eli Lilly and Company"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Eli_Lilly_and_Company" title="Template talk:Eli Lilly and Company"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Eli_Lilly_and_Company" title="Special:EditPage/Template:Eli Lilly and Company"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Eli_Lilly_and_Company" style="font-size:114%;margin:0 4em"><a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Corporation" title="Corporation">Corporate</a> <a href="/wiki/Board_of_directors" title="Board of directors">directors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a></li> <li><a href="/wiki/Ralph_Alvarez" title="Ralph Alvarez">Ralph Alvarez</a></li> <li><a href="/wiki/Winfried_Bischoff" title="Winfried Bischoff">Sir Winfried Bischoff</a></li> <li><a href="/wiki/Michael_L._Eskew" title="Michael L. Eskew">Michael L. Eskew</a></li> <li><a href="/wiki/Martin_Feldstein" title="Martin Feldstein">Martin S. Feldstein</a></li> <li><a href="/w/index.php?title=J._Erik_Fyrwald&amp;action=edit&amp;redlink=1" class="new" title="J. Erik Fyrwald (page does not exist)">J. Erik Fyrwald</a></li> <li><a href="/wiki/Alfred_G._Gilman" title="Alfred G. Gilman">Alfred G. Gilman</a></li> <li><a href="/wiki/Karen_N._Horn" title="Karen N. Horn">Karen N. Horn</a></li> <li><a href="/w/index.php?title=Ellen_R._Marram&amp;action=edit&amp;redlink=1" class="new" title="Ellen R. Marram (page does not exist)">Ellen R. Marram</a></li> <li><a href="/wiki/Douglas_R._Oberhelman" class="mw-redirect" title="Douglas R. Oberhelman">Douglas R. Oberhelman</a></li> <li><a href="/w/index.php?title=Franklyn_G._Prendergast&amp;action=edit&amp;redlink=1" class="new" title="Franklyn G. Prendergast (page does not exist)">Franklyn G. Prendergast</a></li> <li><a href="/wiki/Kathi_Seifert" title="Kathi Seifert">Kathi P. Seifert</a></li></ul> </div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"> <ul><li><a href="/wiki/Adcirca" class="mw-redirect" title="Adcirca">Adcirca</a></li> <li><a href="/wiki/Pemetrexed" title="Pemetrexed">Alimta</a></li> <li><a href="/wiki/Amyvid" class="mw-redirect" title="Amyvid">Amyvid</a></li> <li><a href="/wiki/Bamlanivimab" title="Bamlanivimab">Bamlanivimab</a></li> <li><a href="/wiki/Baqsimi" class="mw-redirect" title="Baqsimi">Baqsimi</a></li> <li><a class="mw-selflink selflink">Baricitinib</a></li> <li><a href="/wiki/Basaglar" class="mw-redirect" title="Basaglar">Basaglar</a></li> <li><a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a></li> <li><a href="/wiki/Duloxetine" title="Duloxetine">Cymbalta</a></li> <li><a href="/wiki/Cyramza" class="mw-redirect" title="Cyramza">Cyramza</a></li> <li><a href="/wiki/Emgality" class="mw-redirect" title="Emgality">Emgality</a></li> <li><a href="/wiki/Erbitux" class="mw-redirect" title="Erbitux">Erbitux</a></li> <li><a href="/wiki/Etesevimab" class="mw-redirect" title="Etesevimab">Etesevimab</a></li> <li><a href="/wiki/Raloxifene" title="Raloxifene">Evista</a></li> <li><a href="/wiki/Teriparatide" title="Teriparatide">Forteo</a></li> <li><a href="/wiki/Gemcitabine" title="Gemcitabine">Gemzar</a></li> <li><a href="/wiki/Glucagon_(medication)" title="Glucagon (medication)">Glucagon</a></li> <li><a href="/wiki/Glyxambi" class="mw-redirect" title="Glyxambi">Glyxambi</a></li> <li><a href="/wiki/Insulin_lispro" title="Insulin lispro">Humalog</a></li> <li><a href="/wiki/Humatrope" class="mw-redirect" title="Humatrope">Humatrope</a></li> <li><a href="/wiki/Humulin" class="mw-redirect" title="Humulin">Humulin</a></li> <li><a href="/wiki/Jardiance" class="mw-redirect" title="Jardiance">Jardiance</a></li> <li><a href="/wiki/Jaypirca" class="mw-redirect" title="Jaypirca">Jaypirca</a></li> <li><a href="/wiki/Jentadueto" class="mw-redirect" title="Jentadueto">Jentadueto</a></li> <li><a href="/wiki/Kisunla" class="mw-redirect" title="Kisunla">Kisunla</a></li> <li><a href="/wiki/Lyumjev" class="mw-redirect" title="Lyumjev">Lyumjev</a></li> <li><a href="/wiki/Olumiant" class="mw-redirect" title="Olumiant">Olumiant</a></li> <li><a href="/wiki/Portrazza" class="mw-redirect" title="Portrazza">Portrazza</a></li> <li><a href="/wiki/Fluoxetine" title="Fluoxetine">Prozac</a></li> <li><a href="/wiki/Retevmo" class="mw-redirect" title="Retevmo">Retevmo</a></li> <li><a href="/wiki/Reyvow" class="mw-redirect" title="Reyvow">Reyvow</a></li> <li><a href="/wiki/Atomoxetine" title="Atomoxetine">Strattera</a></li> <li><a href="/wiki/Olanzapine/fluoxetine" title="Olanzapine/fluoxetine">Symbyax</a></li> <li><a href="/wiki/Synjardy" class="mw-redirect" title="Synjardy">Synjardy</a></li> <li><a href="/wiki/Taltz" class="mw-redirect" title="Taltz">Taltz</a></li> <li><a href="/wiki/Tradjenta" class="mw-redirect" title="Tradjenta">Tradjenta</a></li> <li><a href="/wiki/Trijardy" class="mw-redirect" title="Trijardy">Trijardy</a></li> <li><a href="/wiki/Trulicity" class="mw-redirect" title="Trulicity">Trulicity</a></li> <li><a href="/wiki/Verzenio" class="mw-redirect" title="Verzenio">Verzenio</a></li> <li><a href="/wiki/Drotrecogin_alfa" title="Drotrecogin alfa">Xigris</a></li> <li><a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a></li></ul> </div></td></tr></tbody></table></div> <style data-mw-deduplicate="TemplateStyles:r1130092004">.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-related{font-size:100%;justify-content:flex-start}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;flex:0 0 auto;min-height:24px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;padding:0.15em 0;column-gap:1em;align-items:baseline;margin:0;list-style:none}.mw-parser-output .portal-bar-content-related{margin:0;list-style:none}.mw-parser-output .portal-bar-item{display:inline-block;margin:0.15em 0.2em;min-height:24px;line-height:24px}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap;align-items:baseline}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-related{font-size:100%;align-items:flex-start}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:center;flex:0;column-gap:1em;border-top:1px solid #a2a9b1;margin:0 auto;list-style:none}.mw-parser-output .portal-bar-content-related{border-top:none;margin:0;list-style:none}}.mw-parser-output .navbox+link+.portal-bar,.mw-parser-output .navbox+style+.portal-bar,.mw-parser-output .navbox+link+.portal-bar-bordered,.mw-parser-output .navbox+style+.portal-bar-bordered,.mw-parser-output .sister-bar+link+.portal-bar,.mw-parser-output .sister-bar+style+.portal-bar,.mw-parser-output .portal-bar+.navbox-styles+.navbox,.mw-parser-output .portal-bar+.navbox-styles+.sister-bar{margin-top:-1px}</style><div class="portal-bar noprint metadata noviewer portal-bar-bordered" role="navigation" aria-label="Portals"><span class="portal-bar-header"><a href="/wiki/Wikipedia:Contents/Portals" title="Wikipedia:Contents/Portals">Portals</a>:</span><ul class="portal-bar-content"><li class="portal-bar-item"><span class="nowrap"><span typeof="mw:File"><span><img alt="icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/8px-WHO_Rod.svg.png" decoding="async" width="8" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/12px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/16px-WHO_Rod.svg.png 2x" data-file-width="107" data-file-height="250" /></span></span> </span><a href="/wiki/Portal:Medicine" title="Portal:Medicine">Medicine</a></li><li class="portal-bar-item"><span class="nowrap"><span typeof="mw:File"><a href="/wiki/File:Sida-aids.png" class="mw-file-description"><img alt="icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/19px-Sida-aids.png" decoding="async" width="19" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/29px-Sida-aids.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2f/Sida-aids.png/38px-Sida-aids.png 2x" data-file-width="290" data-file-height="290" /></a></span> </span><a href="/wiki/Portal:Viruses" title="Portal:Viruses">Viruses</a></li><li class="portal-bar-item"><span class="nowrap"><span typeof="mw:File"><a href="/wiki/File:SARS-CoV-2_(Wikimedia_colors).svg" class="mw-file-description"><img alt="virus icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/18px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png" decoding="async" width="18" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/27px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/SARS-CoV-2_%28Wikimedia_colors%29.svg/36px-SARS-CoV-2_%28Wikimedia_colors%29.svg.png 2x" data-file-width="666" data-file-height="711" /></a></span> </span><a href="/wiki/Portal:COVID-19" title="Portal:COVID-19">COVID-19</a></li></ul></div> <!-- NewPP limit report Parsed by mw‐web.codfw.main‐5cd4cd96d5‐jm4md Cached time: 20241127080743 Cache expiry: 2592000 Reduced expiry: false Complications: [vary‐revision‐sha1, show‐toc] CPU time usage: 1.292 seconds Real time usage: 1.648 seconds Preprocessor visited node count: 9438/1000000 Post‐expand include size: 339617/2097152 bytes Template argument size: 8944/2097152 bytes Highest expansion depth: 23/100 Expensive parser function count: 12/500 Unstrip recursion depth: 1/20 Unstrip post‐expand size: 256722/5000000 bytes Lua time usage: 0.710/10.000 seconds Lua memory usage: 9814943/52428800 bytes Number of Wikibase entities loaded: 1/400 --> <!-- Transclusion expansion time report (%,ms,calls,template) 100.00% 1350.208 1 -total 32.99% 445.397 1 Template:Reflist 28.57% 385.757 1 Template:Infobox_drug 23.69% 319.825 1 Template:Infobox 15.51% 209.409 26 Template:Cite_web 10.21% 137.797 16 Template:Cite_journal 9.77% 131.913 12 Template:Navbox 7.34% 99.104 1 Template:Short_description 7.14% 96.452 1 Template:Immunosuppressants 6.08% 82.077 17 Template:Unbulleted_list --> <!-- Saved in parser cache with key enwiki:pcache:idhash:36106433-0!canonical and timestamp 20241127080743 and revision id 1258014091. Rendering was triggered because: page-view --> </div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Baricitinib&amp;oldid=1258014091">https://en.wikipedia.org/w/index.php?title=Baricitinib&amp;oldid=1258014091</a>"</div></div> <div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Anti-inflammatory_agents" title="Category:Anti-inflammatory agents">Anti-inflammatory agents</a></li><li><a href="/wiki/Category:Azetidines" title="Category:Azetidines">Azetidines</a></li><li><a href="/wiki/Category:COVID-19_drug_development" title="Category:COVID-19 drug development">COVID-19 drug development</a></li><li><a href="/wiki/Category:Janus_kinase_inhibitors" title="Category:Janus kinase inhibitors">Janus kinase inhibitors</a></li><li><a href="/wiki/Category:Pyrazoles" title="Category:Pyrazoles">Pyrazoles</a></li><li><a href="/wiki/Category:Pyrrolopyrimidines" title="Category:Pyrrolopyrimidines">Pyrrolopyrimidines</a></li><li><a href="/wiki/Category:Sulfonamides" title="Category:Sulfonamides">Sulfonamides</a></li><li><a href="/wiki/Category:Disease-modifying_antirheumatic_drugs" title="Category:Disease-modifying antirheumatic drugs">Disease-modifying antirheumatic drugs</a></li><li><a href="/wiki/Category:Nitriles" title="Category:Nitriles">Nitriles</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Source_attribution" title="Category:Source attribution">Source attribution</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_February_2023" title="Category:Use dmy dates from February 2023">Use dmy dates from February 2023</a></li><li><a href="/wiki/Category:Drugs_with_non-standard_legal_status" title="Category:Drugs with non-standard legal status">Drugs with non-standard legal status</a></li><li><a href="/wiki/Category:ECHA_InfoCard_ID_from_Wikidata" title="Category:ECHA InfoCard ID from Wikidata">ECHA InfoCard ID from Wikidata</a></li><li><a href="/wiki/Category:Articles_containing_unverified_chemical_infoboxes" title="Category:Articles containing unverified chemical infoboxes">Articles containing unverified chemical infoboxes</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_August_2016" title="Category:Articles containing potentially dated statements from August 2016">Articles containing potentially dated statements from August 2016</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Wikipedia_articles_in_need_of_updating_from_April_2020" title="Category:Wikipedia articles in need of updating from April 2020">Wikipedia articles in need of updating from April 2020</a></li><li><a href="/wiki/Category:All_Wikipedia_articles_in_need_of_updating" title="Category:All Wikipedia articles in need of updating">All Wikipedia articles in need of updating</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_March_2022" title="Category:Articles containing potentially dated statements from March 2022">Articles containing potentially dated statements from March 2022</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2022" title="Category:Articles with unsourced statements from October 2022">Articles with unsourced statements from October 2022</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_April_2021" title="Category:Articles containing potentially dated statements from April 2021">Articles containing potentially dated statements from April 2021</a></li></ul></div></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> <li id="footer-info-lastmod"> This page was last edited on 17 November 2024, at 18:17<span class="anonymous-show">&#160;(UTC)</span>.</li> <li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>; additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Baricitinib&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://wikimediafoundation.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/static/images/footer/wikimedia-button.svg" width="84" height="29" alt="Wikimedia Foundation" loading="lazy"></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/w/resources/assets/poweredby_mediawiki.svg" alt="Powered by MediaWiki" width="88" height="31" loading="lazy"></a></li> </ul> </footer> </div> </div> </div> <div class="vector-settings" id="p-dock-bottom"> <ul></ul> </div><script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.canary-7df8cc9775-gvncv","wgBackendResponseTime":155,"wgPageParseReport":{"limitreport":{"cputime":"1.292","walltime":"1.648","ppvisitednodes":{"value":9438,"limit":1000000},"postexpandincludesize":{"value":339617,"limit":2097152},"templateargumentsize":{"value":8944,"limit":2097152},"expansiondepth":{"value":23,"limit":100},"expensivefunctioncount":{"value":12,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":256722,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00% 1350.208 1 -total"," 32.99% 445.397 1 Template:Reflist"," 28.57% 385.757 1 Template:Infobox_drug"," 23.69% 319.825 1 Template:Infobox"," 15.51% 209.409 26 Template:Cite_web"," 10.21% 137.797 16 Template:Cite_journal"," 9.77% 131.913 12 Template:Navbox"," 7.34% 99.104 1 Template:Short_description"," 7.14% 96.452 1 Template:Immunosuppressants"," 6.08% 82.077 17 Template:Unbulleted_list"]},"scribunto":{"limitreport-timeusage":{"value":"0.710","limit":"10.000"},"limitreport-memusage":{"value":9814943,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-5cd4cd96d5-jm4md","timestamp":"20241127080743","ttl":2592000,"transientcontent":false}}});});</script> <script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Baricitinib","url":"https:\/\/en.wikipedia.org\/wiki\/Baricitinib","sameAs":"http:\/\/www.wikidata.org\/entity\/Q4860707","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q4860707","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2012-06-11T12:55:39Z","dateModified":"2024-11-17T18:17:50Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/a\/ae\/Baricitinib_structure.svg","headline":"chemical compound"}</script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10